CN115260314B - Recombinant thermophilic neutral protease and application thereof in degradation of protein - Google Patents
Recombinant thermophilic neutral protease and application thereof in degradation of protein Download PDFInfo
- Publication number
- CN115260314B CN115260314B CN202210505122.0A CN202210505122A CN115260314B CN 115260314 B CN115260314 B CN 115260314B CN 202210505122 A CN202210505122 A CN 202210505122A CN 115260314 B CN115260314 B CN 115260314B
- Authority
- CN
- China
- Prior art keywords
- ala
- gly
- leu
- val
- pro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108091005507 Neutral proteases Proteins 0.000 title claims abstract description 134
- 108090000145 Bacillolysin Proteins 0.000 title claims abstract description 131
- 102000035092 Neutral proteases Human genes 0.000 title claims abstract description 130
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 25
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 22
- 230000015556 catabolic process Effects 0.000 title description 2
- 238000006731 degradation reaction Methods 0.000 title description 2
- 230000000694 effects Effects 0.000 claims abstract description 57
- 108010076504 Protein Sorting Signals Proteins 0.000 claims abstract description 47
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 39
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract description 39
- 230000028327 secretion Effects 0.000 claims abstract description 39
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 23
- 108091005804 Peptidases Proteins 0.000 claims description 38
- 239000004365 Protease Substances 0.000 claims description 38
- 230000007062 hydrolysis Effects 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- 238000010008 shearing Methods 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 abstract description 55
- 108090000790 Enzymes Proteins 0.000 abstract description 55
- 239000003599 detergent Substances 0.000 abstract description 31
- 229920001184 polypeptide Polymers 0.000 abstract description 18
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 18
- 230000000593 degrading effect Effects 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 10
- 230000003078 antioxidant effect Effects 0.000 abstract description 7
- 102000001554 Hemoglobins Human genes 0.000 abstract description 3
- 108010054147 Hemoglobins Proteins 0.000 abstract description 3
- 244000046052 Phaseolus vulgaris Species 0.000 abstract description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 abstract description 2
- 102000035195 Peptidases Human genes 0.000 description 37
- 230000014509 gene expression Effects 0.000 description 35
- 241000282326 Felis catus Species 0.000 description 27
- 238000006243 chemical reaction Methods 0.000 description 25
- 235000019419 proteases Nutrition 0.000 description 23
- 230000003248 secreting effect Effects 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 18
- 150000001413 amino acids Chemical group 0.000 description 16
- 235000018102 proteins Nutrition 0.000 description 16
- 101150009206 aprE gene Proteins 0.000 description 15
- 239000007788 liquid Substances 0.000 description 15
- 235000019764 Soybean Meal Nutrition 0.000 description 14
- 239000013613 expression plasmid Substances 0.000 description 14
- 239000013604 expression vector Substances 0.000 description 14
- 238000003259 recombinant expression Methods 0.000 description 14
- 239000004455 soybean meal Substances 0.000 description 14
- 239000002609 medium Substances 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 235000010469 Glycine max Nutrition 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 108020004414 DNA Proteins 0.000 description 10
- 244000068988 Glycine max Species 0.000 description 10
- FBNPMTNBFFAMMH-UHFFFAOYSA-N Leu-Val-Arg Natural products CC(C)CC(N)C(=O)NC(C(C)C)C(=O)NC(C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-UHFFFAOYSA-N 0.000 description 10
- 108010083708 leucyl-aspartyl-valine Proteins 0.000 description 10
- 101100106625 Bacillus subtilis (strain 168) yoaW gene Proteins 0.000 description 9
- 241000588724 Escherichia coli Species 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000005406 washing Methods 0.000 description 9
- 239000007844 bleaching agent Substances 0.000 description 8
- 229920000669 heparin Polymers 0.000 description 8
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 8
- 108091008146 restriction endonucleases Proteins 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 239000004094 surface-active agent Substances 0.000 description 8
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 7
- 101100376571 Bacillus subtilis (strain 168) ykwD gene Proteins 0.000 description 7
- 108091005658 Basic proteases Proteins 0.000 description 7
- 108010047495 alanylglycine Proteins 0.000 description 7
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 7
- 229960001008 heparin sodium Drugs 0.000 description 7
- 108010064235 lysylglycine Proteins 0.000 description 7
- 108010017391 lysylvaline Proteins 0.000 description 7
- 108010025826 prolyl-leucyl-arginine Proteins 0.000 description 7
- FBNPMTNBFFAMMH-AVGNSLFASA-N Leu-Val-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-AVGNSLFASA-N 0.000 description 6
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 6
- 241000868182 Thermus thermophilus HB8 Species 0.000 description 6
- 108010044940 alanylglutamine Proteins 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 6
- 108010010430 asparagine-proline-alanine Proteins 0.000 description 6
- 210000000170 cell membrane Anatomy 0.000 description 6
- 238000003776 cleavage reaction Methods 0.000 description 6
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 6
- 108010050848 glycylleucine Proteins 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000007017 scission Effects 0.000 description 6
- 108010061238 threonyl-glycine Proteins 0.000 description 6
- YIGLXQRFQVWFEY-NRPADANISA-N Ala-Gln-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O YIGLXQRFQVWFEY-NRPADANISA-N 0.000 description 5
- GFEDXKNBZMPEDM-KZVJFYERSA-N Ala-Met-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GFEDXKNBZMPEDM-KZVJFYERSA-N 0.000 description 5
- NSTBNYOKCZKOMI-AVGNSLFASA-N Asn-Tyr-Glu Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O NSTBNYOKCZKOMI-AVGNSLFASA-N 0.000 description 5
- 101100437906 Bacillus subtilis (strain 168) bsn gene Proteins 0.000 description 5
- 101100321179 Bacillus subtilis (strain 168) yrrS gene Proteins 0.000 description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- CAXXTYYGFYTBPV-IUCAKERBSA-N Gln-Leu-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CAXXTYYGFYTBPV-IUCAKERBSA-N 0.000 description 5
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 5
- DSFYPIUSAMSERP-IHRRRGAJSA-N Leu-Leu-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N DSFYPIUSAMSERP-IHRRRGAJSA-N 0.000 description 5
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 5
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 5
- 108010008685 alanyl-glutamyl-aspartic acid Proteins 0.000 description 5
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 5
- 108010089442 arginyl-leucyl-alanyl-arginine Proteins 0.000 description 5
- 108010041102 azocasein Proteins 0.000 description 5
- 239000004744 fabric Substances 0.000 description 5
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 5
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 5
- 108010077435 glycyl-phenylalanyl-glycine Proteins 0.000 description 5
- 108010045383 histidyl-glycyl-glutamic acid Proteins 0.000 description 5
- 230000003472 neutralizing effect Effects 0.000 description 5
- 108010026333 seryl-proline Proteins 0.000 description 5
- 239000000600 sorbitol Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 108010058119 tryptophyl-glycyl-glycine Proteins 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- PBAMJJXWDQXOJA-FXQIFTODSA-N Ala-Asp-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PBAMJJXWDQXOJA-FXQIFTODSA-N 0.000 description 4
- ZVFVBBGVOILKPO-WHFBIAKZSA-N Ala-Gly-Ala Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O ZVFVBBGVOILKPO-WHFBIAKZSA-N 0.000 description 4
- LBYMZCVBOKYZNS-CIUDSAMLSA-N Ala-Leu-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O LBYMZCVBOKYZNS-CIUDSAMLSA-N 0.000 description 4
- XWFWAXPOLRTDFZ-FXQIFTODSA-N Ala-Pro-Ser Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O XWFWAXPOLRTDFZ-FXQIFTODSA-N 0.000 description 4
- NCQMBSJGJMYKCK-ZLUOBGJFSA-N Ala-Ser-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O NCQMBSJGJMYKCK-ZLUOBGJFSA-N 0.000 description 4
- VKKYFICVTYKFIO-CIUDSAMLSA-N Arg-Ala-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N VKKYFICVTYKFIO-CIUDSAMLSA-N 0.000 description 4
- LLQIAIUAKGNOSE-NHCYSSNCSA-N Arg-Val-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N LLQIAIUAKGNOSE-NHCYSSNCSA-N 0.000 description 4
- RSMZEHCMIOKNMW-GSSVUCPTSA-N Asp-Thr-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O RSMZEHCMIOKNMW-GSSVUCPTSA-N 0.000 description 4
- 108091026890 Coding region Proteins 0.000 description 4
- VIPDPMHGICREIS-GVXVVHGQSA-N Glu-Val-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O VIPDPMHGICREIS-GVXVVHGQSA-N 0.000 description 4
- HFPVRZWORNJRRC-UWVGGRQHSA-N Gly-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN HFPVRZWORNJRRC-UWVGGRQHSA-N 0.000 description 4
- BMWFDYIYBAFROD-WPRPVWTQSA-N Gly-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN BMWFDYIYBAFROD-WPRPVWTQSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- YPQDTQJBOFOTJQ-SXTJYALSSA-N Ile-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N YPQDTQJBOFOTJQ-SXTJYALSSA-N 0.000 description 4
- UDBPXJNOEWDBDF-XUXIUFHCSA-N Ile-Lys-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)O)N UDBPXJNOEWDBDF-XUXIUFHCSA-N 0.000 description 4
- NTYQUVLERIHPMU-HRCADAONSA-N Met-Phe-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N NTYQUVLERIHPMU-HRCADAONSA-N 0.000 description 4
- SBVPYBFMIGDIDX-SRVKXCTJSA-N Pro-Pro-Pro Chemical compound OC(=O)[C@@H]1CCCN1C(=O)[C@H]1N(C(=O)[C@H]2NCCC2)CCC1 SBVPYBFMIGDIDX-SRVKXCTJSA-N 0.000 description 4
- CXBFHZLODKPIJY-AAEUAGOBSA-N Ser-Gly-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CO)N CXBFHZLODKPIJY-AAEUAGOBSA-N 0.000 description 4
- NLOAIFSWUUFQFR-CIUDSAMLSA-N Ser-Leu-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O NLOAIFSWUUFQFR-CIUDSAMLSA-N 0.000 description 4
- 108090000787 Subtilisin Proteins 0.000 description 4
- KOVXHANYYYMBRF-IRIUXVKKSA-N Tyr-Glu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O KOVXHANYYYMBRF-IRIUXVKKSA-N 0.000 description 4
- TZVUSFMQWPWHON-NHCYSSNCSA-N Val-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N TZVUSFMQWPWHON-NHCYSSNCSA-N 0.000 description 4
- SDUBQHUJJWQTEU-XUXIUFHCSA-N Val-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](C(C)C)N SDUBQHUJJWQTEU-XUXIUFHCSA-N 0.000 description 4
- 108010087924 alanylproline Proteins 0.000 description 4
- 229960000723 ampicillin Drugs 0.000 description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
- 108010031045 aspartyl-glycyl-aspartyl-alanine Proteins 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 108010051307 glycyl-glycyl-proline Proteins 0.000 description 4
- 108010079413 glycyl-prolyl-glutamic acid Proteins 0.000 description 4
- 108010036413 histidylglycine Proteins 0.000 description 4
- 108010028295 histidylhistidine Proteins 0.000 description 4
- 230000003301 hydrolyzing effect Effects 0.000 description 4
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 108010077112 prolyl-proline Proteins 0.000 description 4
- 108010031719 prolyl-serine Proteins 0.000 description 4
- 108010029020 prolylglycine Proteins 0.000 description 4
- 108010048397 seryl-lysyl-leucine Proteins 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000000108 ultra-filtration Methods 0.000 description 4
- SBGXWWCLHIOABR-UHFFFAOYSA-N Ala Ala Gly Ala Chemical compound CC(N)C(=O)NC(C)C(=O)NCC(=O)NC(C)C(O)=O SBGXWWCLHIOABR-UHFFFAOYSA-N 0.000 description 3
- XCVRVWZTXPCYJT-BIIVOSGPSA-N Ala-Asn-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N XCVRVWZTXPCYJT-BIIVOSGPSA-N 0.000 description 3
- KIUYPHAMDKDICO-WHFBIAKZSA-N Ala-Asp-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O KIUYPHAMDKDICO-WHFBIAKZSA-N 0.000 description 3
- KXEVYGKATAMXJJ-ACZMJKKPSA-N Ala-Glu-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O KXEVYGKATAMXJJ-ACZMJKKPSA-N 0.000 description 3
- OBVSBEYOMDWLRJ-BFHQHQDPSA-N Ala-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N OBVSBEYOMDWLRJ-BFHQHQDPSA-N 0.000 description 3
- VQAVBBCZFQAAED-FXQIFTODSA-N Ala-Pro-Asn Chemical compound C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N)C(=O)O)N VQAVBBCZFQAAED-FXQIFTODSA-N 0.000 description 3
- FSXDWQGEWZQBPJ-HERUPUMHSA-N Ala-Trp-Asp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)O)C(=O)O)N FSXDWQGEWZQBPJ-HERUPUMHSA-N 0.000 description 3
- DBKNLHKEVPZVQC-LPEHRKFASA-N Arg-Ala-Pro Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@@H]1C(O)=O DBKNLHKEVPZVQC-LPEHRKFASA-N 0.000 description 3
- GIVATXIGCXFQQA-FXQIFTODSA-N Arg-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N GIVATXIGCXFQQA-FXQIFTODSA-N 0.000 description 3
- CYXCAHZVPFREJD-LURJTMIESA-N Arg-Gly-Gly Chemical compound NC(=N)NCCC[C@H](N)C(=O)NCC(=O)NCC(O)=O CYXCAHZVPFREJD-LURJTMIESA-N 0.000 description 3
- WLVLIYYBPPONRJ-GCJQMDKQSA-N Asn-Thr-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O WLVLIYYBPPONRJ-GCJQMDKQSA-N 0.000 description 3
- ZSJFGGSPCCHMNE-LAEOZQHASA-N Asp-Gln-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)O)N ZSJFGGSPCCHMNE-LAEOZQHASA-N 0.000 description 3
- GHODABZPVZMWCE-FXQIFTODSA-N Asp-Glu-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O GHODABZPVZMWCE-FXQIFTODSA-N 0.000 description 3
- MYOHQBFRJQFIDZ-KKUMJFAQSA-N Asp-Leu-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MYOHQBFRJQFIDZ-KKUMJFAQSA-N 0.000 description 3
- RPUYTJJZXQBWDT-SRVKXCTJSA-N Asp-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N RPUYTJJZXQBWDT-SRVKXCTJSA-N 0.000 description 3
- USENATHVGFXRNO-SRVKXCTJSA-N Asp-Tyr-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(O)=O)CC1=CC=C(O)C=C1 USENATHVGFXRNO-SRVKXCTJSA-N 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- XBELMDARIGXDKY-GUBZILKMSA-N Cys-Pro-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)N XBELMDARIGXDKY-GUBZILKMSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- SHERTACNJPYHAR-ACZMJKKPSA-N Gln-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O SHERTACNJPYHAR-ACZMJKKPSA-N 0.000 description 3
- PIUPHASDUFSHTF-CIUDSAMLSA-N Gln-Pro-Asn Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)N)N)C(=O)N[C@@H](CC(=O)N)C(=O)O PIUPHASDUFSHTF-CIUDSAMLSA-N 0.000 description 3
- KUBFPYIMAGXGBT-ACZMJKKPSA-N Gln-Ser-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O KUBFPYIMAGXGBT-ACZMJKKPSA-N 0.000 description 3
- SJMJMEWQMBJYPR-DZKIICNBSA-N Gln-Tyr-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCC(=O)N)N SJMJMEWQMBJYPR-DZKIICNBSA-N 0.000 description 3
- OJGLIOXAKGFFDW-SRVKXCTJSA-N Glu-Arg-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)N OJGLIOXAKGFFDW-SRVKXCTJSA-N 0.000 description 3
- SUIAHERNFYRBDZ-GVXVVHGQSA-N Glu-Lys-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O SUIAHERNFYRBDZ-GVXVVHGQSA-N 0.000 description 3
- KIEICAOUSNYOLM-NRPADANISA-N Glu-Val-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O KIEICAOUSNYOLM-NRPADANISA-N 0.000 description 3
- RLFSBAPJTYKSLG-WHFBIAKZSA-N Gly-Ala-Asp Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O RLFSBAPJTYKSLG-WHFBIAKZSA-N 0.000 description 3
- QSDKBRMVXSWAQE-BFHQHQDPSA-N Gly-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN QSDKBRMVXSWAQE-BFHQHQDPSA-N 0.000 description 3
- AIJAPFVDBFYNKN-WHFBIAKZSA-N Gly-Asn-Asp Chemical compound C([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)CN)C(=O)N AIJAPFVDBFYNKN-WHFBIAKZSA-N 0.000 description 3
- UEGIPZAXNBYCCP-NKWVEPMBSA-N Gly-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)CN)C(=O)O UEGIPZAXNBYCCP-NKWVEPMBSA-N 0.000 description 3
- LHRXAHLCRMQBGJ-RYUDHWBXSA-N Gly-Glu-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CN LHRXAHLCRMQBGJ-RYUDHWBXSA-N 0.000 description 3
- SWQALSGKVLYKDT-ZKWXMUAHSA-N Gly-Ile-Ala Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O SWQALSGKVLYKDT-ZKWXMUAHSA-N 0.000 description 3
- ULZCYBYDTUMHNF-IUCAKERBSA-N Gly-Leu-Glu Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ULZCYBYDTUMHNF-IUCAKERBSA-N 0.000 description 3
- CCBIBMKQNXHNIN-ZETCQYMHSA-N Gly-Leu-Gly Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CCBIBMKQNXHNIN-ZETCQYMHSA-N 0.000 description 3
- FGPLUIQCSKGLTI-WDSKDSINSA-N Gly-Ser-Glu Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O FGPLUIQCSKGLTI-WDSKDSINSA-N 0.000 description 3
- DUAWRXXTOQOECJ-JSGCOSHPSA-N Gly-Tyr-Val Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O DUAWRXXTOQOECJ-JSGCOSHPSA-N 0.000 description 3
- YDIDLLVFCYSXNY-RCOVLWMOSA-N Gly-Val-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN YDIDLLVFCYSXNY-RCOVLWMOSA-N 0.000 description 3
- SYOJVRNQCXYEOV-XVKPBYJWSA-N Gly-Val-Glu Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SYOJVRNQCXYEOV-XVKPBYJWSA-N 0.000 description 3
- HAPWZEVRQYGLSG-IUCAKERBSA-N His-Gly-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O HAPWZEVRQYGLSG-IUCAKERBSA-N 0.000 description 3
- YHFPHRUWZMEOIX-CYDGBPFRSA-N Ile-Val-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)O)N YHFPHRUWZMEOIX-CYDGBPFRSA-N 0.000 description 3
- 108010065920 Insulin Lispro Proteins 0.000 description 3
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 3
- QCSFMCFHVGTLFF-NHCYSSNCSA-N Leu-Asp-Val Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O QCSFMCFHVGTLFF-NHCYSSNCSA-N 0.000 description 3
- GPICTNQYKHHHTH-GUBZILKMSA-N Leu-Gln-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O GPICTNQYKHHHTH-GUBZILKMSA-N 0.000 description 3
- WQWSMEOYXJTFRU-GUBZILKMSA-N Leu-Glu-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O WQWSMEOYXJTFRU-GUBZILKMSA-N 0.000 description 3
- OXRLYTYUXAQTHP-YUMQZZPRSA-N Leu-Gly-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(O)=O OXRLYTYUXAQTHP-YUMQZZPRSA-N 0.000 description 3
- YFBBUHJJUXXZOF-UWVGGRQHSA-N Leu-Gly-Pro Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O YFBBUHJJUXXZOF-UWVGGRQHSA-N 0.000 description 3
- CFZZDVMBRYFFNU-QWRGUYRKSA-N Leu-His-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)NCC(O)=O CFZZDVMBRYFFNU-QWRGUYRKSA-N 0.000 description 3
- WMIOEVKKYIMVKI-DCAQKATOSA-N Leu-Pro-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O WMIOEVKKYIMVKI-DCAQKATOSA-N 0.000 description 3
- YRWCPXOFBKTCFY-NUTKFTJISA-N Lys-Ala-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CCCCN)N YRWCPXOFBKTCFY-NUTKFTJISA-N 0.000 description 3
- CLBGMWIYPYAZPR-AVGNSLFASA-N Lys-Arg-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O CLBGMWIYPYAZPR-AVGNSLFASA-N 0.000 description 3
- QKXZCUCBFPEXNK-KKUMJFAQSA-N Lys-Leu-His Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 QKXZCUCBFPEXNK-KKUMJFAQSA-N 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- APJPXSFJBMMOLW-KBPBESRZSA-N Phe-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 APJPXSFJBMMOLW-KBPBESRZSA-N 0.000 description 3
- AUJWXNGCAQWLEI-KBPBESRZSA-N Phe-Lys-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O AUJWXNGCAQWLEI-KBPBESRZSA-N 0.000 description 3
- DOXQMJCSSYZSNM-BZSNNMDCSA-N Phe-Lys-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O DOXQMJCSSYZSNM-BZSNNMDCSA-N 0.000 description 3
- IAOZOFPONWDXNT-IXOXFDKPSA-N Phe-Ser-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IAOZOFPONWDXNT-IXOXFDKPSA-N 0.000 description 3
- VFDRDMOMHBJGKD-UFYCRDLUSA-N Phe-Tyr-Arg Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N VFDRDMOMHBJGKD-UFYCRDLUSA-N 0.000 description 3
- SWXSLPHTJVAWDF-VEVYYDQMSA-N Pro-Asn-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SWXSLPHTJVAWDF-VEVYYDQMSA-N 0.000 description 3
- WPQKSRHDTMRSJM-CIUDSAMLSA-N Pro-Asp-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1 WPQKSRHDTMRSJM-CIUDSAMLSA-N 0.000 description 3
- FKLSMYYLJHYPHH-UWVGGRQHSA-N Pro-Gly-Leu Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O FKLSMYYLJHYPHH-UWVGGRQHSA-N 0.000 description 3
- YXHYJEPDKSYPSQ-AVGNSLFASA-N Pro-Leu-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 YXHYJEPDKSYPSQ-AVGNSLFASA-N 0.000 description 3
- BGWKULMLUIUPKY-BQBZGAKWSA-N Pro-Ser-Gly Chemical compound OC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1 BGWKULMLUIUPKY-BQBZGAKWSA-N 0.000 description 3
- SNGZLPOXVRTNMB-LPEHRKFASA-N Pro-Ser-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CO)C(=O)N2CCC[C@@H]2C(=O)O SNGZLPOXVRTNMB-LPEHRKFASA-N 0.000 description 3
- BRKHVZNDAOMAHX-BIIVOSGPSA-N Ser-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N BRKHVZNDAOMAHX-BIIVOSGPSA-N 0.000 description 3
- PZZJMBYSYAKYPK-UWJYBYFXSA-N Ser-Ala-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O PZZJMBYSYAKYPK-UWJYBYFXSA-N 0.000 description 3
- GJFYFGOEWLDQGW-GUBZILKMSA-N Ser-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CO)N GJFYFGOEWLDQGW-GUBZILKMSA-N 0.000 description 3
- XNCUYZKGQOCOQH-YUMQZZPRSA-N Ser-Leu-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O XNCUYZKGQOCOQH-YUMQZZPRSA-N 0.000 description 3
- QJKPECIAWNNKIT-KKUMJFAQSA-N Ser-Lys-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O QJKPECIAWNNKIT-KKUMJFAQSA-N 0.000 description 3
- XVWDJUROVRQKAE-KKUMJFAQSA-N Ser-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CC1=CC=CC=C1 XVWDJUROVRQKAE-KKUMJFAQSA-N 0.000 description 3
- YEDSOSIKVUMIJE-DCAQKATOSA-N Ser-Val-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O YEDSOSIKVUMIJE-DCAQKATOSA-N 0.000 description 3
- 108010022999 Serine Proteases Proteins 0.000 description 3
- 102000012479 Serine Proteases Human genes 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 108090001109 Thermolysin Proteins 0.000 description 3
- YOSLMIPKOUAHKI-OLHMAJIHSA-N Thr-Asp-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O YOSLMIPKOUAHKI-OLHMAJIHSA-N 0.000 description 3
- KCRQEJSKXAIULJ-FJXKBIBVSA-N Thr-Gly-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O KCRQEJSKXAIULJ-FJXKBIBVSA-N 0.000 description 3
- XFTYVCHLARBHBQ-FOHZUACHSA-N Thr-Gly-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O XFTYVCHLARBHBQ-FOHZUACHSA-N 0.000 description 3
- XEVHXNLPUBVQEX-DVJZZOLTSA-N Thr-Trp-Gly Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)NCC(=O)O)N)O XEVHXNLPUBVQEX-DVJZZOLTSA-N 0.000 description 3
- BVDHHLMIZFCAAU-BZSNNMDCSA-N Tyr-Cys-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O BVDHHLMIZFCAAU-BZSNNMDCSA-N 0.000 description 3
- XJPXTYLVMUZGNW-IHRRRGAJSA-N Tyr-Pro-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O XJPXTYLVMUZGNW-IHRRRGAJSA-N 0.000 description 3
- YKBUNNNRNZZUID-UFYCRDLUSA-N Tyr-Val-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YKBUNNNRNZZUID-UFYCRDLUSA-N 0.000 description 3
- VPGCVZRRBYOGCD-AVGNSLFASA-N Val-Lys-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O VPGCVZRRBYOGCD-AVGNSLFASA-N 0.000 description 3
- BGXVHVMJZCSOCA-AVGNSLFASA-N Val-Pro-Lys Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)N BGXVHVMJZCSOCA-AVGNSLFASA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 108010069020 alanyl-prolyl-glycine Proteins 0.000 description 3
- 108010086434 alanyl-seryl-glycine Proteins 0.000 description 3
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 3
- 108010038633 aspartylglutamate Proteins 0.000 description 3
- 108010068265 aspartyltyrosine Proteins 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 230000007071 enzymatic hydrolysis Effects 0.000 description 3
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 108010053037 kyotorphin Proteins 0.000 description 3
- KNMNNEPMKDJBDW-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-1-(2,6-dimethylphenoxy)propan-2-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCNC(C)COC1=C(C)C=CC=C1C KNMNNEPMKDJBDW-UHFFFAOYSA-N 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 230000010355 oscillation Effects 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 108010051242 phenylalanylserine Proteins 0.000 description 3
- 239000008055 phosphate buffer solution Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 230000001131 transforming effect Effects 0.000 description 3
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 3
- 108010084932 tryptophyl-proline Proteins 0.000 description 3
- 108010087967 type I signal peptidase Proteins 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- COEXAQSTZUWMRI-STQMWFEESA-N (2s)-1-[2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]pyrrolidine-2-carboxylic acid Chemical compound C([C@H](N)C(=O)NCC(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=C(O)C=C1 COEXAQSTZUWMRI-STQMWFEESA-N 0.000 description 2
- IGXNPQWXIRIGBF-KEOOTSPTSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoic acid Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 IGXNPQWXIRIGBF-KEOOTSPTSA-N 0.000 description 2
- SHYYAQLDNVHPFT-DLOVCJGASA-N Ala-Asn-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SHYYAQLDNVHPFT-DLOVCJGASA-N 0.000 description 2
- BLGHHPHXVJWCNK-GUBZILKMSA-N Ala-Gln-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O BLGHHPHXVJWCNK-GUBZILKMSA-N 0.000 description 2
- SMCGQGDVTPFXKB-XPUUQOCRSA-N Ala-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N SMCGQGDVTPFXKB-XPUUQOCRSA-N 0.000 description 2
- RGQCNKIDEQJEBT-CQDKDKBSSA-N Ala-Leu-Tyr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 RGQCNKIDEQJEBT-CQDKDKBSSA-N 0.000 description 2
- RIPMDCIXRYWXSH-KNXALSJPSA-N Ala-Trp-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N3CCC[C@@H]3C(=O)O)N RIPMDCIXRYWXSH-KNXALSJPSA-N 0.000 description 2
- ZJLORAAXDAJLDC-CQDKDKBSSA-N Ala-Tyr-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O ZJLORAAXDAJLDC-CQDKDKBSSA-N 0.000 description 2
- SGYSTDWPNPKJPP-GUBZILKMSA-N Arg-Ala-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SGYSTDWPNPKJPP-GUBZILKMSA-N 0.000 description 2
- NGYHSXDNNOFHNE-AVGNSLFASA-N Arg-Pro-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O NGYHSXDNNOFHNE-AVGNSLFASA-N 0.000 description 2
- MFFOYNGMOYFPBD-DCAQKATOSA-N Asn-Arg-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O MFFOYNGMOYFPBD-DCAQKATOSA-N 0.000 description 2
- KXFCBAHYSLJCCY-ZLUOBGJFSA-N Asn-Asn-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O KXFCBAHYSLJCCY-ZLUOBGJFSA-N 0.000 description 2
- JRVABKHPWDRUJF-UBHSHLNASA-N Asn-Asn-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N JRVABKHPWDRUJF-UBHSHLNASA-N 0.000 description 2
- UGXVKHRDGLYFKR-CIUDSAMLSA-N Asn-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(N)=O UGXVKHRDGLYFKR-CIUDSAMLSA-N 0.000 description 2
- GNKVBRYFXYWXAB-WDSKDSINSA-N Asn-Glu-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O GNKVBRYFXYWXAB-WDSKDSINSA-N 0.000 description 2
- BXUHCIXDSWRSBS-CIUDSAMLSA-N Asn-Leu-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O BXUHCIXDSWRSBS-CIUDSAMLSA-N 0.000 description 2
- PLTGTJAZQRGMPP-FXQIFTODSA-N Asn-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O PLTGTJAZQRGMPP-FXQIFTODSA-N 0.000 description 2
- UGXYFDQFLVCDFC-CIUDSAMLSA-N Asn-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O UGXYFDQFLVCDFC-CIUDSAMLSA-N 0.000 description 2
- DAYDURRBMDCCFL-AAEUAGOBSA-N Asn-Trp-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC(=O)N)N DAYDURRBMDCCFL-AAEUAGOBSA-N 0.000 description 2
- DPSUVAPLRQDWAO-YDHLFZDLSA-N Asn-Tyr-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)N DPSUVAPLRQDWAO-YDHLFZDLSA-N 0.000 description 2
- KDFQZBWWPYQBEN-ZLUOBGJFSA-N Asp-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N KDFQZBWWPYQBEN-ZLUOBGJFSA-N 0.000 description 2
- DXQOQMCLWWADMU-ACZMJKKPSA-N Asp-Gln-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O DXQOQMCLWWADMU-ACZMJKKPSA-N 0.000 description 2
- AHWRSSLYSGLBGD-CIUDSAMLSA-N Asp-Pro-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O AHWRSSLYSGLBGD-CIUDSAMLSA-N 0.000 description 2
- WMLFFCRUSPNENW-ZLUOBGJFSA-N Asp-Ser-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O WMLFFCRUSPNENW-ZLUOBGJFSA-N 0.000 description 2
- UTLCRGFJFSZWAW-OLHMAJIHSA-N Asp-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O UTLCRGFJFSZWAW-OLHMAJIHSA-N 0.000 description 2
- XWKBWZXGNXTDKY-ZKWXMUAHSA-N Asp-Val-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC(O)=O XWKBWZXGNXTDKY-ZKWXMUAHSA-N 0.000 description 2
- 108091006146 Channels Proteins 0.000 description 2
- VPQZSNQICFCCSO-BJDJZHNGSA-N Cys-Leu-Ile Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VPQZSNQICFCCSO-BJDJZHNGSA-N 0.000 description 2
- GFMJUESGWILPEN-MELADBBJSA-N Cys-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CS)N)C(=O)O GFMJUESGWILPEN-MELADBBJSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 102000010911 Enzyme Precursors Human genes 0.000 description 2
- 108010062466 Enzyme Precursors Proteins 0.000 description 2
- UVAOVENCIONMJP-GUBZILKMSA-N Gln-Cys-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O UVAOVENCIONMJP-GUBZILKMSA-N 0.000 description 2
- KVQOVQVGVKDZNW-GUBZILKMSA-N Gln-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N)N KVQOVQVGVKDZNW-GUBZILKMSA-N 0.000 description 2
- LPIKVBWNNVFHCQ-GUBZILKMSA-N Gln-Ser-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O LPIKVBWNNVFHCQ-GUBZILKMSA-N 0.000 description 2
- VLOLPWWCNKWRNB-LOKLDPHHSA-N Gln-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O VLOLPWWCNKWRNB-LOKLDPHHSA-N 0.000 description 2
- JVSBYEDSSRZQGV-GUBZILKMSA-N Glu-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCC(O)=O JVSBYEDSSRZQGV-GUBZILKMSA-N 0.000 description 2
- OWVURWCRZZMAOZ-XHNCKOQMSA-N Glu-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)N)C(=O)O OWVURWCRZZMAOZ-XHNCKOQMSA-N 0.000 description 2
- LGYZYFFDELZWRS-DCAQKATOSA-N Glu-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O LGYZYFFDELZWRS-DCAQKATOSA-N 0.000 description 2
- HVYWQYLBVXMXSV-GUBZILKMSA-N Glu-Leu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HVYWQYLBVXMXSV-GUBZILKMSA-N 0.000 description 2
- PJBVXVBTTFZPHJ-GUBZILKMSA-N Glu-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)N PJBVXVBTTFZPHJ-GUBZILKMSA-N 0.000 description 2
- UGSVSNXPJJDJKL-SDDRHHMPSA-N Glu-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N UGSVSNXPJJDJKL-SDDRHHMPSA-N 0.000 description 2
- ZIYGTCDTJJCDDP-JYJNAYRXSA-N Glu-Phe-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N ZIYGTCDTJJCDDP-JYJNAYRXSA-N 0.000 description 2
- AAJHGGDRKHYSDH-GUBZILKMSA-N Glu-Pro-Gln Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O AAJHGGDRKHYSDH-GUBZILKMSA-N 0.000 description 2
- HAGKYCXGTRUUFI-RYUDHWBXSA-N Glu-Tyr-Gly Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)O)N)O HAGKYCXGTRUUFI-RYUDHWBXSA-N 0.000 description 2
- RJIVPOXLQFJRTG-LURJTMIESA-N Gly-Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N RJIVPOXLQFJRTG-LURJTMIESA-N 0.000 description 2
- WKJKBELXHCTHIJ-WPRPVWTQSA-N Gly-Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N WKJKBELXHCTHIJ-WPRPVWTQSA-N 0.000 description 2
- GGEJHJIXRBTJPD-BYPYZUCNSA-N Gly-Asn-Gly Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GGEJHJIXRBTJPD-BYPYZUCNSA-N 0.000 description 2
- YYPFZVIXAVDHIK-IUCAKERBSA-N Gly-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CN YYPFZVIXAVDHIK-IUCAKERBSA-N 0.000 description 2
- KMSGYZQRXPUKGI-BYPYZUCNSA-N Gly-Gly-Asn Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(N)=O KMSGYZQRXPUKGI-BYPYZUCNSA-N 0.000 description 2
- BUEFQXUHTUZXHR-LURJTMIESA-N Gly-Gly-Pro zwitterion Chemical compound NCC(=O)NCC(=O)N1CCC[C@H]1C(O)=O BUEFQXUHTUZXHR-LURJTMIESA-N 0.000 description 2
- INLIXXRWNUKVCF-JTQLQIEISA-N Gly-Gly-Tyr Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 INLIXXRWNUKVCF-JTQLQIEISA-N 0.000 description 2
- IGOYNRWLWHWAQO-JTQLQIEISA-N Gly-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 IGOYNRWLWHWAQO-JTQLQIEISA-N 0.000 description 2
- JJGBXTYGTKWGAT-YUMQZZPRSA-N Gly-Pro-Glu Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O JJGBXTYGTKWGAT-YUMQZZPRSA-N 0.000 description 2
- HAOUOFNNJJLVNS-BQBZGAKWSA-N Gly-Pro-Ser Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O HAOUOFNNJJLVNS-BQBZGAKWSA-N 0.000 description 2
- TVTZEOHWHUVYCG-KYNKHSRBSA-N Gly-Thr-Thr Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O TVTZEOHWHUVYCG-KYNKHSRBSA-N 0.000 description 2
- RGPWUJOMKFYFSR-QWRGUYRKSA-N His-Gly-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O RGPWUJOMKFYFSR-QWRGUYRKSA-N 0.000 description 2
- STOOMQFEJUVAKR-KKUMJFAQSA-N His-His-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)C1=CNC=N1 STOOMQFEJUVAKR-KKUMJFAQSA-N 0.000 description 2
- SLFSYFJKSIVSON-SRVKXCTJSA-N His-Met-Glu Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N SLFSYFJKSIVSON-SRVKXCTJSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- NCSIQAFSIPHVAN-IUKAMOBKSA-N Ile-Asn-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N NCSIQAFSIPHVAN-IUKAMOBKSA-N 0.000 description 2
- YJRSIJZUIUANHO-NAKRPEOUSA-N Ile-Val-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)O)N YJRSIJZUIUANHO-NAKRPEOUSA-N 0.000 description 2
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 2
- 241000880493 Leptailurus serval Species 0.000 description 2
- LJHGALIOHLRRQN-DCAQKATOSA-N Leu-Ala-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N LJHGALIOHLRRQN-DCAQKATOSA-N 0.000 description 2
- IGUOAYLTQJLPPD-DCAQKATOSA-N Leu-Asn-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IGUOAYLTQJLPPD-DCAQKATOSA-N 0.000 description 2
- BPANDPNDMJHFEV-CIUDSAMLSA-N Leu-Asp-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O BPANDPNDMJHFEV-CIUDSAMLSA-N 0.000 description 2
- ILJREDZFPHTUIE-GUBZILKMSA-N Leu-Asp-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ILJREDZFPHTUIE-GUBZILKMSA-N 0.000 description 2
- VGPCJSXPPOQPBK-YUMQZZPRSA-N Leu-Gly-Ser Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O VGPCJSXPPOQPBK-YUMQZZPRSA-N 0.000 description 2
- JKSIBWITFMQTOA-XUXIUFHCSA-N Leu-Ile-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O JKSIBWITFMQTOA-XUXIUFHCSA-N 0.000 description 2
- CPONGMJGVIAWEH-DCAQKATOSA-N Leu-Met-Ala Chemical compound CSCC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(O)=O CPONGMJGVIAWEH-DCAQKATOSA-N 0.000 description 2
- PJWOOBTYQNNRBF-BZSNNMDCSA-N Leu-Phe-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)O)N PJWOOBTYQNNRBF-BZSNNMDCSA-N 0.000 description 2
- XWEVVRRSIOBJOO-SRVKXCTJSA-N Leu-Pro-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O XWEVVRRSIOBJOO-SRVKXCTJSA-N 0.000 description 2
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 2
- CGHXMODRYJISSK-NHCYSSNCSA-N Leu-Val-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(O)=O CGHXMODRYJISSK-NHCYSSNCSA-N 0.000 description 2
- LCMWVZLBCUVDAZ-IUCAKERBSA-N Lys-Gly-Glu Chemical compound [NH3+]CCCC[C@H]([NH3+])C(=O)NCC(=O)N[C@H](C([O-])=O)CCC([O-])=O LCMWVZLBCUVDAZ-IUCAKERBSA-N 0.000 description 2
- DTUZCYRNEJDKSR-NHCYSSNCSA-N Lys-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN DTUZCYRNEJDKSR-NHCYSSNCSA-N 0.000 description 2
- HAUUXTXKJNVIFY-ONGXEEELSA-N Lys-Gly-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O HAUUXTXKJNVIFY-ONGXEEELSA-N 0.000 description 2
- MIMXMVDLMDMOJD-BZSNNMDCSA-N Lys-Tyr-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O MIMXMVDLMDMOJD-BZSNNMDCSA-N 0.000 description 2
- OZVXDDFYCQOPFD-XQQFMLRXSA-N Lys-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N OZVXDDFYCQOPFD-XQQFMLRXSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- DSZFTPCSFVWMKP-DCAQKATOSA-N Met-Ser-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN DSZFTPCSFVWMKP-DCAQKATOSA-N 0.000 description 2
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 2
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 2
- VLZGUAUYZGQKPM-DRZSPHRISA-N Phe-Gln-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O VLZGUAUYZGQKPM-DRZSPHRISA-N 0.000 description 2
- VIIRRNQMMIHYHQ-XHSDSOJGSA-N Phe-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N VIIRRNQMMIHYHQ-XHSDSOJGSA-N 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- IWNOFCGBMSFTBC-CIUDSAMLSA-N Pro-Ala-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IWNOFCGBMSFTBC-CIUDSAMLSA-N 0.000 description 2
- XQLBWXHVZVBNJM-FXQIFTODSA-N Pro-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 XQLBWXHVZVBNJM-FXQIFTODSA-N 0.000 description 2
- WWAQEUOYCYMGHB-FXQIFTODSA-N Pro-Asn-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1 WWAQEUOYCYMGHB-FXQIFTODSA-N 0.000 description 2
- JFNPBBOGGNMSRX-CIUDSAMLSA-N Pro-Gln-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O JFNPBBOGGNMSRX-CIUDSAMLSA-N 0.000 description 2
- QGOZJLYCGRYYRW-KKUMJFAQSA-N Pro-Glu-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O QGOZJLYCGRYYRW-KKUMJFAQSA-N 0.000 description 2
- VYWNORHENYEQDW-YUMQZZPRSA-N Pro-Gly-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 VYWNORHENYEQDW-YUMQZZPRSA-N 0.000 description 2
- DXTOOBDIIAJZBJ-BQBZGAKWSA-N Pro-Gly-Ser Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(O)=O DXTOOBDIIAJZBJ-BQBZGAKWSA-N 0.000 description 2
- HAEGAELAYWSUNC-WPRPVWTQSA-N Pro-Gly-Val Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O HAEGAELAYWSUNC-WPRPVWTQSA-N 0.000 description 2
- VWXGFAIZUQBBBG-UWVGGRQHSA-N Pro-His-Gly Chemical compound C([C@@H](C(=O)NCC(=O)[O-])NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 VWXGFAIZUQBBBG-UWVGGRQHSA-N 0.000 description 2
- LXLFEIHKWGHJJB-XUXIUFHCSA-N Pro-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1 LXLFEIHKWGHJJB-XUXIUFHCSA-N 0.000 description 2
- SUENWIFTSTWUKD-AVGNSLFASA-N Pro-Leu-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O SUENWIFTSTWUKD-AVGNSLFASA-N 0.000 description 2
- ULWBBFKQBDNGOY-RWMBFGLXSA-N Pro-Lys-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@@H]2C(=O)O ULWBBFKQBDNGOY-RWMBFGLXSA-N 0.000 description 2
- KBUAPZAZPWNYSW-SRVKXCTJSA-N Pro-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 KBUAPZAZPWNYSW-SRVKXCTJSA-N 0.000 description 2
- SXJOPONICMGFCR-DCAQKATOSA-N Pro-Ser-Lys Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O SXJOPONICMGFCR-DCAQKATOSA-N 0.000 description 2
- QUBVFEANYYWBTM-VEVYYDQMSA-N Pro-Thr-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O QUBVFEANYYWBTM-VEVYYDQMSA-N 0.000 description 2
- ZAUHSLVPDLNTRZ-QXEWZRGKSA-N Pro-Val-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O ZAUHSLVPDLNTRZ-QXEWZRGKSA-N 0.000 description 2
- 102100038946 Proprotein convertase subtilisin/kexin type 6 Human genes 0.000 description 2
- IDCKUIWEIZYVSO-WFBYXXMGSA-N Ser-Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C)C(O)=O)=CNC2=C1 IDCKUIWEIZYVSO-WFBYXXMGSA-N 0.000 description 2
- PVDTYLHUWAEYGY-CIUDSAMLSA-N Ser-Glu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PVDTYLHUWAEYGY-CIUDSAMLSA-N 0.000 description 2
- BPMRXBZYPGYPJN-WHFBIAKZSA-N Ser-Gly-Asn Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O BPMRXBZYPGYPJN-WHFBIAKZSA-N 0.000 description 2
- IOVBCLGAJJXOHK-SRVKXCTJSA-N Ser-His-His Chemical compound C([C@H](NC(=O)[C@H](CO)N)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 IOVBCLGAJJXOHK-SRVKXCTJSA-N 0.000 description 2
- QYSFWUIXDFJUDW-DCAQKATOSA-N Ser-Leu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYSFWUIXDFJUDW-DCAQKATOSA-N 0.000 description 2
- JLKWJWPDXPKKHI-FXQIFTODSA-N Ser-Pro-Asn Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CO)N)C(=O)N[C@@H](CC(=O)N)C(=O)O JLKWJWPDXPKKHI-FXQIFTODSA-N 0.000 description 2
- 101710135785 Subtilisin-like protease Proteins 0.000 description 2
- 108010056079 Subtilisins Proteins 0.000 description 2
- 102000005158 Subtilisins Human genes 0.000 description 2
- 241000589499 Thermus thermophilus Species 0.000 description 2
- VIBXMCZWVUOZLA-OLHMAJIHSA-N Thr-Asn-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O VIBXMCZWVUOZLA-OLHMAJIHSA-N 0.000 description 2
- BVOVIGCHYNFJBZ-JXUBOQSCSA-N Thr-Leu-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O BVOVIGCHYNFJBZ-JXUBOQSCSA-N 0.000 description 2
- PRNGXSILMXSWQQ-OEAJRASXSA-N Thr-Leu-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PRNGXSILMXSWQQ-OEAJRASXSA-N 0.000 description 2
- MROIJTGJGIDEEJ-RCWTZXSCSA-N Thr-Pro-Pro Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 MROIJTGJGIDEEJ-RCWTZXSCSA-N 0.000 description 2
- AHERARIZBPOMNU-KATARQTJSA-N Thr-Ser-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O AHERARIZBPOMNU-KATARQTJSA-N 0.000 description 2
- GRIUMVXCJDKVPI-IZPVPAKOSA-N Thr-Thr-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O GRIUMVXCJDKVPI-IZPVPAKOSA-N 0.000 description 2
- REJRKTOJTCPDPO-IRIUXVKKSA-N Thr-Tyr-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O REJRKTOJTCPDPO-IRIUXVKKSA-N 0.000 description 2
- WACMTVIJWRNVSO-CWRNSKLLSA-N Trp-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N)C(=O)O WACMTVIJWRNVSO-CWRNSKLLSA-N 0.000 description 2
- OZUJUVFWMHTWCZ-HOCLYGCPSA-N Trp-Gly-His Chemical compound N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O OZUJUVFWMHTWCZ-HOCLYGCPSA-N 0.000 description 2
- LGEYOIQBBIPHQN-UWJYBYFXSA-N Tyr-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 LGEYOIQBBIPHQN-UWJYBYFXSA-N 0.000 description 2
- XHALUUQSNXSPLP-UFYCRDLUSA-N Tyr-Arg-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 XHALUUQSNXSPLP-UFYCRDLUSA-N 0.000 description 2
- CRWOSTCODDFEKZ-HRCADAONSA-N Tyr-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)O CRWOSTCODDFEKZ-HRCADAONSA-N 0.000 description 2
- YGKVNUAKYPGORG-AVGNSLFASA-N Tyr-Asp-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YGKVNUAKYPGORG-AVGNSLFASA-N 0.000 description 2
- CWQZAUYFWRLITN-AVGNSLFASA-N Tyr-Gln-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N)O CWQZAUYFWRLITN-AVGNSLFASA-N 0.000 description 2
- MVFQLSPDMMFCMW-KKUMJFAQSA-N Tyr-Leu-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O MVFQLSPDMMFCMW-KKUMJFAQSA-N 0.000 description 2
- KHPLUFDSWGDRHD-SLFFLAALSA-N Tyr-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N)C(=O)O KHPLUFDSWGDRHD-SLFFLAALSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- AZSHAZJLOZQYAY-FXQIFTODSA-N Val-Ala-Ser Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O AZSHAZJLOZQYAY-FXQIFTODSA-N 0.000 description 2
- VDPRBUOZLIFUIM-GUBZILKMSA-N Val-Arg-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C(C)C)N VDPRBUOZLIFUIM-GUBZILKMSA-N 0.000 description 2
- JYVKKBDANPZIAW-AVGNSLFASA-N Val-Arg-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C(C)C)N JYVKKBDANPZIAW-AVGNSLFASA-N 0.000 description 2
- IDKGBVZGNTYYCC-QXEWZRGKSA-N Val-Asn-Pro Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(O)=O IDKGBVZGNTYYCC-QXEWZRGKSA-N 0.000 description 2
- PWRITNSESKQTPW-NRPADANISA-N Val-Gln-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N PWRITNSESKQTPW-NRPADANISA-N 0.000 description 2
- CELJCNRXKZPTCX-XPUUQOCRSA-N Val-Gly-Ala Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O CELJCNRXKZPTCX-XPUUQOCRSA-N 0.000 description 2
- RSGHLMMKXJGCMK-JYJNAYRXSA-N Val-Met-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N RSGHLMMKXJGCMK-JYJNAYRXSA-N 0.000 description 2
- AIWLHFZYOUUJGB-UFYCRDLUSA-N Val-Phe-Tyr Chemical compound C([C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 AIWLHFZYOUUJGB-UFYCRDLUSA-N 0.000 description 2
- SJRUJQFQVLMZFW-WPRPVWTQSA-N Val-Pro-Gly Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O SJRUJQFQVLMZFW-WPRPVWTQSA-N 0.000 description 2
- USLVEJAHTBLSIL-CYDGBPFRSA-N Val-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C USLVEJAHTBLSIL-CYDGBPFRSA-N 0.000 description 2
- UGFMVXRXULGLNO-XPUUQOCRSA-N Val-Ser-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O UGFMVXRXULGLNO-XPUUQOCRSA-N 0.000 description 2
- DOBHJKVVACOQTN-DZKIICNBSA-N Val-Tyr-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=C(O)C=C1 DOBHJKVVACOQTN-DZKIICNBSA-N 0.000 description 2
- JSOXWWFKRJKTMT-WOPDTQHZSA-N Val-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N JSOXWWFKRJKTMT-WOPDTQHZSA-N 0.000 description 2
- 108010041407 alanylaspartic acid Proteins 0.000 description 2
- 108010070944 alanylhistidine Proteins 0.000 description 2
- 108010070783 alanyltyrosine Proteins 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 108010062796 arginyllysine Proteins 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 108010027668 glycyl-alanyl-valine Proteins 0.000 description 2
- 108010074027 glycyl-seryl-phenylalanine Proteins 0.000 description 2
- 108010089804 glycyl-threonine Proteins 0.000 description 2
- 108010084389 glycyltryptophan Proteins 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 108010020132 microbial serine proteinases Proteins 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 108010015796 prolylisoleucine Proteins 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 108010048818 seryl-histidine Proteins 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- CIJQGPVMMRXSQW-UHFFFAOYSA-M sodium;2-aminoacetic acid;hydroxide Chemical compound O.[Na+].NCC([O-])=O CIJQGPVMMRXSQW-UHFFFAOYSA-M 0.000 description 2
- 108010038745 tryptophylglycine Proteins 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 108091005508 Acid proteases Proteins 0.000 description 1
- YYSWCHMLFJLLBJ-ZLUOBGJFSA-N Ala-Ala-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YYSWCHMLFJLLBJ-ZLUOBGJFSA-N 0.000 description 1
- DVWVZSJAYIJZFI-FXQIFTODSA-N Ala-Arg-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O DVWVZSJAYIJZFI-FXQIFTODSA-N 0.000 description 1
- QDRGPQWIVZNJQD-CIUDSAMLSA-N Ala-Arg-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O QDRGPQWIVZNJQD-CIUDSAMLSA-N 0.000 description 1
- BTYTYHBSJKQBQA-GCJQMDKQSA-N Ala-Asp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N)O BTYTYHBSJKQBQA-GCJQMDKQSA-N 0.000 description 1
- FUSPCLTUKXQREV-ACZMJKKPSA-N Ala-Glu-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O FUSPCLTUKXQREV-ACZMJKKPSA-N 0.000 description 1
- IXTPACPAXIOCRG-ACZMJKKPSA-N Ala-Glu-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N IXTPACPAXIOCRG-ACZMJKKPSA-N 0.000 description 1
- MQIGTEQXYCRLGK-BQBZGAKWSA-N Ala-Gly-Pro Chemical compound C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O MQIGTEQXYCRLGK-BQBZGAKWSA-N 0.000 description 1
- GRPHQEMIFDPKOE-HGNGGELXSA-N Ala-His-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O GRPHQEMIFDPKOE-HGNGGELXSA-N 0.000 description 1
- AAXVGJXZKHQQHD-LSJOCFKGSA-N Ala-His-Met Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCSC)C(=O)O)N AAXVGJXZKHQQHD-LSJOCFKGSA-N 0.000 description 1
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 1
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 1
- RTZCUEHYUQZIDE-WHFBIAKZSA-N Ala-Ser-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RTZCUEHYUQZIDE-WHFBIAKZSA-N 0.000 description 1
- MMLHRUJLOUSRJX-CIUDSAMLSA-N Ala-Ser-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN MMLHRUJLOUSRJX-CIUDSAMLSA-N 0.000 description 1
- NZGRHTKZFSVPAN-BIIVOSGPSA-N Ala-Ser-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N NZGRHTKZFSVPAN-BIIVOSGPSA-N 0.000 description 1
- ARHJJAAWNWOACN-FXQIFTODSA-N Ala-Ser-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O ARHJJAAWNWOACN-FXQIFTODSA-N 0.000 description 1
- CREYEAPXISDKSB-FQPOAREZSA-N Ala-Thr-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CREYEAPXISDKSB-FQPOAREZSA-N 0.000 description 1
- VHAQSYHSDKERBS-XPUUQOCRSA-N Ala-Val-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O VHAQSYHSDKERBS-XPUUQOCRSA-N 0.000 description 1
- RVDVDRUZWZIBJQ-CIUDSAMLSA-N Arg-Asn-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O RVDVDRUZWZIBJQ-CIUDSAMLSA-N 0.000 description 1
- OTZMRMHZCMZOJZ-SRVKXCTJSA-N Arg-Leu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O OTZMRMHZCMZOJZ-SRVKXCTJSA-N 0.000 description 1
- SLQQPJBDBVPVQV-JYJNAYRXSA-N Arg-Phe-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O SLQQPJBDBVPVQV-JYJNAYRXSA-N 0.000 description 1
- PJOPLXOCKACMLK-KKUMJFAQSA-N Arg-Tyr-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O PJOPLXOCKACMLK-KKUMJFAQSA-N 0.000 description 1
- FMYQECOAIFGQGU-CYDGBPFRSA-N Arg-Val-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FMYQECOAIFGQGU-CYDGBPFRSA-N 0.000 description 1
- HOIFSHOLNKQCSA-FXQIFTODSA-N Asn-Arg-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O HOIFSHOLNKQCSA-FXQIFTODSA-N 0.000 description 1
- KUYKVGODHGHFDI-ACZMJKKPSA-N Asn-Gln-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O KUYKVGODHGHFDI-ACZMJKKPSA-N 0.000 description 1
- KLKHFFMNGWULBN-VKHMYHEASA-N Asn-Gly Chemical compound NC(=O)C[C@H](N)C(=O)NCC(O)=O KLKHFFMNGWULBN-VKHMYHEASA-N 0.000 description 1
- SEKBHZJLARBNPB-GHCJXIJMSA-N Asn-Ile-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O SEKBHZJLARBNPB-GHCJXIJMSA-N 0.000 description 1
- IDUUACUJKUXKKD-VEVYYDQMSA-N Asn-Pro-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O IDUUACUJKUXKKD-VEVYYDQMSA-N 0.000 description 1
- QIRJQYQOIKBPBZ-IHRRRGAJSA-N Asn-Tyr-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QIRJQYQOIKBPBZ-IHRRRGAJSA-N 0.000 description 1
- OERMIMJQPQUIPK-FXQIFTODSA-N Asp-Arg-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O OERMIMJQPQUIPK-FXQIFTODSA-N 0.000 description 1
- QXHVOUSPVAWEMX-ZLUOBGJFSA-N Asp-Asp-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O QXHVOUSPVAWEMX-ZLUOBGJFSA-N 0.000 description 1
- YDJVIBMKAMQPPP-LAEOZQHASA-N Asp-Glu-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O YDJVIBMKAMQPPP-LAEOZQHASA-N 0.000 description 1
- XLILXFRAKOYEJX-GUBZILKMSA-N Asp-Leu-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O XLILXFRAKOYEJX-GUBZILKMSA-N 0.000 description 1
- AYFVRYXNDHBECD-YUMQZZPRSA-N Asp-Leu-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O AYFVRYXNDHBECD-YUMQZZPRSA-N 0.000 description 1
- UJGRZQYSNYTCAX-SRVKXCTJSA-N Asp-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UJGRZQYSNYTCAX-SRVKXCTJSA-N 0.000 description 1
- YRZIYQGXTSBRLT-AVGNSLFASA-N Asp-Phe-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O YRZIYQGXTSBRLT-AVGNSLFASA-N 0.000 description 1
- 102000035101 Aspartic proteases Human genes 0.000 description 1
- 108091005502 Aspartic proteases Proteins 0.000 description 1
- 241000020089 Atacta Species 0.000 description 1
- 101000973805 Bacillus caldolyticus Bacillolysin Proteins 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- KSMSFCBQBQPFAD-GUBZILKMSA-N Cys-Pro-Pro Chemical compound SC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 KSMSFCBQBQPFAD-GUBZILKMSA-N 0.000 description 1
- 102000005927 Cysteine Proteases Human genes 0.000 description 1
- 108010005843 Cysteine Proteases Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 241000626621 Geobacillus Species 0.000 description 1
- NNQHEEQNPQYPGL-FXQIFTODSA-N Gln-Ala-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O NNQHEEQNPQYPGL-FXQIFTODSA-N 0.000 description 1
- HYPVLWGNBIYTNA-GUBZILKMSA-N Gln-Leu-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HYPVLWGNBIYTNA-GUBZILKMSA-N 0.000 description 1
- SDSMVVSHLAAOJL-UKJIMTQDSA-N Gln-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)N SDSMVVSHLAAOJL-UKJIMTQDSA-N 0.000 description 1
- CSMHMEATMDCQNY-DZKIICNBSA-N Gln-Val-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CSMHMEATMDCQNY-DZKIICNBSA-N 0.000 description 1
- PAQUJCSYVIBPLC-AVGNSLFASA-N Glu-Asp-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PAQUJCSYVIBPLC-AVGNSLFASA-N 0.000 description 1
- VGBSZQSKQRMLHD-MNXVOIDGSA-N Glu-Leu-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VGBSZQSKQRMLHD-MNXVOIDGSA-N 0.000 description 1
- KXTAGESXNQEZKB-DZKIICNBSA-N Glu-Phe-Val Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=CC=C1 KXTAGESXNQEZKB-DZKIICNBSA-N 0.000 description 1
- BPLNJYHNAJVLRT-ACZMJKKPSA-N Glu-Ser-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O BPLNJYHNAJVLRT-ACZMJKKPSA-N 0.000 description 1
- YQAQQKPWFOBSMU-WDCWCFNPSA-N Glu-Thr-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O YQAQQKPWFOBSMU-WDCWCFNPSA-N 0.000 description 1
- GZUKEVBTYNNUQF-WDSKDSINSA-N Gly-Ala-Gln Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O GZUKEVBTYNNUQF-WDSKDSINSA-N 0.000 description 1
- FKJQNJCQTKUBCD-XPUUQOCRSA-N Gly-Ala-His Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O FKJQNJCQTKUBCD-XPUUQOCRSA-N 0.000 description 1
- LURCIJSJAKFCRO-QWRGUYRKSA-N Gly-Asn-Tyr Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LURCIJSJAKFCRO-QWRGUYRKSA-N 0.000 description 1
- KQDMENMTYNBWMR-WHFBIAKZSA-N Gly-Asp-Ala Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O KQDMENMTYNBWMR-WHFBIAKZSA-N 0.000 description 1
- MOJKRXIRAZPZLW-WDSKDSINSA-N Gly-Glu-Ala Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O MOJKRXIRAZPZLW-WDSKDSINSA-N 0.000 description 1
- SOEATRRYCIPEHA-BQBZGAKWSA-N Gly-Glu-Glu Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SOEATRRYCIPEHA-BQBZGAKWSA-N 0.000 description 1
- CCQOOWAONKGYKQ-BYPYZUCNSA-N Gly-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)CN CCQOOWAONKGYKQ-BYPYZUCNSA-N 0.000 description 1
- ADZGCWWDPFDHCY-ZETCQYMHSA-N Gly-His-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 ADZGCWWDPFDHCY-ZETCQYMHSA-N 0.000 description 1
- NNCSJUBVFBDDLC-YUMQZZPRSA-N Gly-Leu-Ser Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O NNCSJUBVFBDDLC-YUMQZZPRSA-N 0.000 description 1
- JSLVAHYTAJJEQH-QWRGUYRKSA-N Gly-Ser-Phe Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JSLVAHYTAJJEQH-QWRGUYRKSA-N 0.000 description 1
- GULGDABMYTYMJZ-STQMWFEESA-N Gly-Trp-Asp Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(O)=O)C(O)=O GULGDABMYTYMJZ-STQMWFEESA-N 0.000 description 1
- GJHWILMUOANXTG-WPRPVWTQSA-N Gly-Val-Arg Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GJHWILMUOANXTG-WPRPVWTQSA-N 0.000 description 1
- NGRPGJGKJMUGDM-XVKPBYJWSA-N Gly-Val-Gln Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O NGRPGJGKJMUGDM-XVKPBYJWSA-N 0.000 description 1
- BAYQNCWLXIDLHX-ONGXEEELSA-N Gly-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN BAYQNCWLXIDLHX-ONGXEEELSA-N 0.000 description 1
- KSOBNUBCYHGUKH-UWVGGRQHSA-N Gly-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN KSOBNUBCYHGUKH-UWVGGRQHSA-N 0.000 description 1
- SDTPKSOWFXBACN-GUBZILKMSA-N His-Glu-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O SDTPKSOWFXBACN-GUBZILKMSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- APDIECQNNDGFPD-PYJNHQTQSA-N Ile-His-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](C(C)C)C(=O)O)N APDIECQNNDGFPD-PYJNHQTQSA-N 0.000 description 1
- VEPIBPGLTLPBDW-URLPEUOOSA-N Ile-Phe-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N VEPIBPGLTLPBDW-URLPEUOOSA-N 0.000 description 1
- PELCGFMHLZXWBQ-BJDJZHNGSA-N Ile-Ser-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)N PELCGFMHLZXWBQ-BJDJZHNGSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108090000862 Ion Channels Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- UGTHTQWIQKEDEH-BQBZGAKWSA-N L-alanyl-L-prolylglycine zwitterion Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UGTHTQWIQKEDEH-BQBZGAKWSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- LHSGPCFBGJHPCY-UHFFFAOYSA-N L-leucine-L-tyrosine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-UHFFFAOYSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- PBCHMHROGNUXMK-DLOVCJGASA-N Leu-Ala-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 PBCHMHROGNUXMK-DLOVCJGASA-N 0.000 description 1
- WSGXUIQTEZDVHJ-GARJFASQSA-N Leu-Ala-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@@H]1C(O)=O WSGXUIQTEZDVHJ-GARJFASQSA-N 0.000 description 1
- DLCOFDAHNMMQPP-SRVKXCTJSA-N Leu-Asp-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DLCOFDAHNMMQPP-SRVKXCTJSA-N 0.000 description 1
- CLVUXCBGKUECIT-HJGDQZAQSA-N Leu-Asp-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CLVUXCBGKUECIT-HJGDQZAQSA-N 0.000 description 1
- VWHGTYCRDRBSFI-ZETCQYMHSA-N Leu-Gly-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)NCC(O)=O VWHGTYCRDRBSFI-ZETCQYMHSA-N 0.000 description 1
- USLNHQZCDQJBOV-ZPFDUUQYSA-N Leu-Ile-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O USLNHQZCDQJBOV-ZPFDUUQYSA-N 0.000 description 1
- UBZGNBKMIJHOHL-BZSNNMDCSA-N Leu-Leu-Phe Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 UBZGNBKMIJHOHL-BZSNNMDCSA-N 0.000 description 1
- YIRIDPUGZKHMHT-ACRUOGEOSA-N Leu-Tyr-Tyr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YIRIDPUGZKHMHT-ACRUOGEOSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- LJADEBULDNKJNK-IHRRRGAJSA-N Lys-Leu-Val Chemical compound CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O LJADEBULDNKJNK-IHRRRGAJSA-N 0.000 description 1
- HVAUKHLDSDDROB-KKUMJFAQSA-N Lys-Lys-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O HVAUKHLDSDDROB-KKUMJFAQSA-N 0.000 description 1
- PDIDTSZKKFEDMB-UWVGGRQHSA-N Lys-Pro-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O PDIDTSZKKFEDMB-UWVGGRQHSA-N 0.000 description 1
- SUZVLFWOCKHWET-CQDKDKBSSA-N Lys-Tyr-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O SUZVLFWOCKHWET-CQDKDKBSSA-N 0.000 description 1
- OHXUUQDOBQKSNB-AVGNSLFASA-N Lys-Val-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O OHXUUQDOBQKSNB-AVGNSLFASA-N 0.000 description 1
- TXTZMVNJIRZABH-ULQDDVLXSA-N Lys-Val-Phe Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 TXTZMVNJIRZABH-ULQDDVLXSA-N 0.000 description 1
- WYEXWKAWMNJKPN-UBHSHLNASA-N Met-Ala-Phe Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCSC)N WYEXWKAWMNJKPN-UBHSHLNASA-N 0.000 description 1
- AHZNUGRZHMZGFL-GUBZILKMSA-N Met-Arg-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CCCNC(N)=N AHZNUGRZHMZGFL-GUBZILKMSA-N 0.000 description 1
- SJDQOYTYNGZZJX-SRVKXCTJSA-N Met-Glu-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O SJDQOYTYNGZZJX-SRVKXCTJSA-N 0.000 description 1
- PCTFVQATEGYHJU-FXQIFTODSA-N Met-Ser-Asn Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O PCTFVQATEGYHJU-FXQIFTODSA-N 0.000 description 1
- KYXDADPHSNFWQX-VEVYYDQMSA-N Met-Thr-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(O)=O KYXDADPHSNFWQX-VEVYYDQMSA-N 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 1
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 1
- MMJJFXWMCMJMQA-STQMWFEESA-N Phe-Pro-Gly Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)C1=CC=CC=C1 MMJJFXWMCMJMQA-STQMWFEESA-N 0.000 description 1
- AFNJAQVMTIQTCB-DLOVCJGASA-N Phe-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=CC=C1 AFNJAQVMTIQTCB-DLOVCJGASA-N 0.000 description 1
- KIZQGKLMXKGDIV-BQBZGAKWSA-N Pro-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 KIZQGKLMXKGDIV-BQBZGAKWSA-N 0.000 description 1
- SMCHPSMKAFIERP-FXQIFTODSA-N Pro-Asn-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@@H]1CCCN1 SMCHPSMKAFIERP-FXQIFTODSA-N 0.000 description 1
- MLQVJYMFASXBGZ-IHRRRGAJSA-N Pro-Asn-Tyr Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O MLQVJYMFASXBGZ-IHRRRGAJSA-N 0.000 description 1
- XZONQWUEBAFQPO-HJGDQZAQSA-N Pro-Gln-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XZONQWUEBAFQPO-HJGDQZAQSA-N 0.000 description 1
- ZUGXSSFMTXKHJS-ZLUOBGJFSA-N Ser-Ala-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O ZUGXSSFMTXKHJS-ZLUOBGJFSA-N 0.000 description 1
- COAHUSQNSVFYBW-FXQIFTODSA-N Ser-Asn-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O COAHUSQNSVFYBW-FXQIFTODSA-N 0.000 description 1
- DSGYZICNAMEJOC-AVGNSLFASA-N Ser-Glu-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O DSGYZICNAMEJOC-AVGNSLFASA-N 0.000 description 1
- SFTZWNJFZYOLBD-ZDLURKLDSA-N Ser-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO SFTZWNJFZYOLBD-ZDLURKLDSA-N 0.000 description 1
- XXXAXOWMBOKTRN-XPUUQOCRSA-N Ser-Gly-Val Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXXAXOWMBOKTRN-XPUUQOCRSA-N 0.000 description 1
- FUMGHWDRRFCKEP-CIUDSAMLSA-N Ser-Leu-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O FUMGHWDRRFCKEP-CIUDSAMLSA-N 0.000 description 1
- OWCVUSJMEBGMOK-YUMQZZPRSA-N Ser-Lys-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O OWCVUSJMEBGMOK-YUMQZZPRSA-N 0.000 description 1
- PJIQEIFXZPCWOJ-FXQIFTODSA-N Ser-Pro-Asp Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O PJIQEIFXZPCWOJ-FXQIFTODSA-N 0.000 description 1
- LLSLRQOEAFCZLW-NRPADANISA-N Ser-Val-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O LLSLRQOEAFCZLW-NRPADANISA-N 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- JKGGPMOUIAAJAA-YEPSODPASA-N Thr-Gly-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O JKGGPMOUIAAJAA-YEPSODPASA-N 0.000 description 1
- BIBYEFRASCNLAA-CDMKHQONSA-N Thr-Phe-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 BIBYEFRASCNLAA-CDMKHQONSA-N 0.000 description 1
- CSZFFQBUTMGHAH-UAXMHLISSA-N Thr-Thr-Trp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N)O CSZFFQBUTMGHAH-UAXMHLISSA-N 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- JVTHMUDOKPQBOT-NSHDSACASA-N Trp-Gly-Gly Chemical compound C1=CC=C2C(C[C@H]([NH3+])C(=O)NCC(=O)NCC([O-])=O)=CNC2=C1 JVTHMUDOKPQBOT-NSHDSACASA-N 0.000 description 1
- SAKLWFSRZTZQAJ-GQGQLFGLSA-N Trp-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N SAKLWFSRZTZQAJ-GQGQLFGLSA-N 0.000 description 1
- OJKVFAWXPGCJMF-BPUTZDHNSA-N Trp-Pro-Ser Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC2=CNC3=CC=CC=C32)N)C(=O)N[C@@H](CO)C(=O)O OJKVFAWXPGCJMF-BPUTZDHNSA-N 0.000 description 1
- NOOMDULIORCDNF-IRXDYDNUSA-N Tyr-Gly-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O NOOMDULIORCDNF-IRXDYDNUSA-N 0.000 description 1
- ARJASMXQBRNAGI-YESZJQIVSA-N Tyr-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N ARJASMXQBRNAGI-YESZJQIVSA-N 0.000 description 1
- KLOZTPOXVVRVAQ-DZKIICNBSA-N Tyr-Val-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 KLOZTPOXVVRVAQ-DZKIICNBSA-N 0.000 description 1
- DJIJBQYBDKGDIS-JYJNAYRXSA-N Tyr-Val-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(O)=O DJIJBQYBDKGDIS-JYJNAYRXSA-N 0.000 description 1
- LNYOXPDEIZJDEI-NHCYSSNCSA-N Val-Asn-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)N LNYOXPDEIZJDEI-NHCYSSNCSA-N 0.000 description 1
- AGKDVLSDNSTLFA-UMNHJUIQSA-N Val-Gln-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N AGKDVLSDNSTLFA-UMNHJUIQSA-N 0.000 description 1
- UEHRGZCNLSWGHK-DLOVCJGASA-N Val-Glu-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O UEHRGZCNLSWGHK-DLOVCJGASA-N 0.000 description 1
- YTPLVNUZZOBFFC-SCZZXKLOSA-N Val-Gly-Pro Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N1CCC[C@@H]1C(O)=O YTPLVNUZZOBFFC-SCZZXKLOSA-N 0.000 description 1
- DJQIUOKSNRBTSV-CYDGBPFRSA-N Val-Ile-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](C(C)C)N DJQIUOKSNRBTSV-CYDGBPFRSA-N 0.000 description 1
- UMPVMAYCLYMYGA-ONGXEEELSA-N Val-Leu-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O UMPVMAYCLYMYGA-ONGXEEELSA-N 0.000 description 1
- VSCIANXXVZOYOC-AVGNSLFASA-N Val-Pro-His Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N VSCIANXXVZOYOC-AVGNSLFASA-N 0.000 description 1
- JXCOEPXCBVCTRD-JYJNAYRXSA-N Val-Tyr-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N JXCOEPXCBVCTRD-JYJNAYRXSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 108010077245 asparaginyl-proline Proteins 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 108010092854 aspartyllysine Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- PGWTYMLATMNCCZ-UHFFFAOYSA-M azure A Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 PGWTYMLATMNCCZ-UHFFFAOYSA-M 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 108010060199 cysteinylproline Proteins 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- 239000007986 glycine-NaOH buffer Substances 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- 108010019832 glycyl-asparaginyl-glycine Proteins 0.000 description 1
- 108010010096 glycyl-glycyl-tyrosine Proteins 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 210000003000 inclusion body Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000003262 industrial enzyme Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 108010078274 isoleucylvaline Proteins 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- 108010012058 leucyltyrosine Proteins 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 108010003855 mesentericopeptidase Proteins 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 108010056582 methionylglutamic acid Proteins 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 108010070409 phenylalanyl-glycyl-glycine Proteins 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 108010090894 prolylleucine Proteins 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000004153 renaturation Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960001922 sodium perborate Drugs 0.000 description 1
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 108010020532 tyrosyl-proline Proteins 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0081—Reaction with amino acids, peptides, or proteins
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38618—Protease or amylase in liquid compositions only
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21014—Microbial serine proteases (3.4.21.14)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Water Supply & Treatment (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Sustainable Development (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
A recombinant thermophilic neutral protease and application thereof in degrading protein belong to the technical field of bioengineering. The invention provides a recombinant thermophilic neutral protease capable of being secreted and expressed in a bacillus subtilis host, which comprises the recombinant thermophilic neutral protease with secretion signal peptide sequences shown in SEQ ID No.1, SEQ ID No.3, SEQ ID No.4, SEQ ID No.5 and SEQ ID No.6 and the recombinant thermophilic neutral protease without secretion signal peptide sequences shown in SEQ ID No.2. The thermophilic neutral protease is secreted and expressed in bacillus subtilis in the form of a pro-peptide sequence, and experimental results show that the thermophilic neutral protease has higher enzyme activity, can degrade bean pulp to obtain small molecular polypeptides with high antioxidant activity, can stably exert the enzyme activity in various detergents, can well degrade hemoglobin and remove blood stains.
Description
Technical Field
The invention belongs to the technical field of bioengineering, and particularly relates to recombinant thermophilic neutral protease capable of being secreted and expressed in a bacillus subtilis host and application of the recombinant thermophilic neutral protease in protein degradation.
Background
Proteases are a class of hydrolytic enzymes that cleave peptide bonds in macromolecular proteins to make them small molecular proteins or polypeptides. The types of amino acid residues at the active center can be classified into serine protease, cysteine protease, aspartic protease and metalloprotease, and the pH of the reaction can be classified into acid protease, neutral protease and alkaline protease.
Proteases find wide application in industry. In the medical field, protease is one of the pharmaceutical enzymes with earliest clinical use and widest application, and can be used for treating dyspepsia, diminishing inflammation, activating blood vessels and treating hypertension. In the food industry, proteases are used for meat softening, cheese production, beer decontamination, peptone production and the like. Proteases are one of the main enzymes added in enzymatic detergents for the removal of proteinaceous soils. Besides being added into daily detergents, the protease can also be used in medical multi-enzyme detergents for degrading hemoglobin and the like on surgical instruments. The protease added in the detergent is mainly from Bacillus, including wild type enzyme and mutant, such as subtilisin Carlsberg (ALCALASE) produced by Novozymes company Ⓡ ) Subtilisin 147 (ESPERASE) Ⓡ ) Subtilisin 309 (SAVINASE) Ⓡ ) And subtilisin PB92 from Genencor (MAXACAL) Ⓡ ) Etc. The novelin company published a subtilisin mutant in patent CN 101228343B; patent CN 1606626a discloses a novel alkaline protease of bacillus species (DSM 14390) and washing and cleaning products comprising the novel alkaline protease; CN 103305493a and CN 103305493B disclose the production and use of thermophilic proteases and mutants from geobacillus, which are at P at 32 ℃ in liquid detergents>IDE Ⓡ Is 68 times more stable than NprE purified from the bacillus species supernatant. Protease main added in enzyme-added detergent in domestic market at presentThe development of proteases with high activity and stability is important in economic, social and environmental benefits by virtue of importation and high price.
Neutral protease is protease with optimal reaction pH of 7.0, and has been used in food, detergent and textile industries. However, the enzyme preparation enterprises which are currently engaged in the research and the sales of neutral protease are few, so that the research and the development of the neutral protease have better research and application prospects.
Chinese patent CN 1446911a discloses a method for producing thermolysin by artificial gene, constructing escherichia coli expression strain to induce expression of thermolysin, but the expression product is inclusion body, and needs to use high concentration urea for renaturation. This enzyme is well known in the literature under the english name Thermolysin, which is known in Ca 2+ The enzyme can exist stably at 80 ℃, but has limited cleavage sites, which only cut at the N end of hydrophobic amino acid residues, including methionine, leucine, isoleucine, valine, phenylalanine and alanine, and limited cleavage sites, so that the enzyme is commonly used for polypeptide profiling and rarely used for other purposes. CN 103667150 discloses bacillus subtilis for producing thermostable neutral protease, the optimum reaction temperature of the neutral protease is 70 ℃, the optimum reaction pH is 7.2, the enzyme activity is reduced by 5% in 30 min at 60 ℃, the enzyme activity is reduced by 15% in 1 h, and the stability is limited.
The condition of the enzyme is complex in practical application, while the disadvantage of neutral protease is poor stability, which limits its application range. Compared with chemical catalysts, thermophilic enzymes from thermophilic and hyperthermophilic microorganisms have the advantages of high catalytic efficiency, strong substrate specificity, good stability and the like, and are a very potential source of industrial enzymes. Therefore, the development of a thermophilic neutral protease with high activity and stability can provide a good candidate enzyme for industrial proteases.
We report from thermophilic archaebacteriaThermus thermophilus HB8Inducible expression of the thermophilic protease of (E.coli host) (Xie GQ, shao ZK, zong L, et al Heterologous expression and characterization of anoverl subtilisin-like protease from a thermophilic Thermus thermophilus H)B8,International journal of biological macromolecules, 2019, 138: 528-535.). The enzyme belongs to a Subtilisin-like protease family, and is analyzed by similarity comparison, the sequence contains secretion signal peptide (1-19), a propeptide sequence and a mature protease sequence, the sequence needs to be removed when the enzyme is expressed in escherichia coli, the coding sequence with the propeptide amino acid sequence is connected to an escherichia coli expression vector pET20b through PCR amplification, and only the mature protease after self-shearing is obtained after induction expression, heat treatment and purification. Mature enzyme shows maximum catalytic activity at 65-80 ℃ and pH 7.5, the half-life of enzyme at 75 ℃ exceeds 48 h, the half-life of enzyme at 85 ℃ also exceeds 3 h, and the mature enzyme has very high stability. Subtilisin-like family proteases have no specific cleavage sites and are more suitable for industrial use in degrading proteins.
Disclosure of Invention
The invention aims to provide a recombinant thermophilic neutral protease which can be secreted and expressed in a bacillus subtilis host and application of the thermophilic neutral protease in degrading proteins, wherein the recombinant thermophilic neutral protease comprises recombinant thermophilic neutral proteases with secretion signal peptide sequences (the amino acid sequences are shown as SEQ ID No.1, SEQ ID No.3, SEQ ID No.4, SEQ ID No.5 and SEQ ID No. 6) and recombinant thermophilic neutral proteases without secretion signal peptide sequences (the amino acid sequences are shown as SEQ ID No. 2).
The recombinant thermophilic neutral protease of the invention is derived from thermophilic bacteriaThermus thermophilus HB8Serine proteases belonging to the subtilisin-like family. The recombinant thermophilic neutral protease is constructed on a bacillus subtilis expression vector pBE-S in the form of a propeptide sequence, and is fused with a secretion signal peptide aprE on the vector for expression, the nucleotide sequence and the amino acid sequence of the fusion protein are shown as SEQ ID No.1, wherein 1-87 nucleotide sequences are coding sequences (coding 1-29 amino acid sequences) of the secretion signal peptide aprE, 88-111 nucleotide sequences are identification sequences (coding 30-37 amino acid sequences) of restriction enzymes on the vector, 112-390 nucleotide sequences are coding sequences (coding 38-130 amino acid sequences) of the propeptide, and 391-1353 nucleotide sequencesThe coding sequence is listed as mature enzyme coding sequence (coding 131-451 amino acid sequences), and the 1354-1407 nucleotide sequence is the coding sequence (coding 452-468 amino acid sequences) of restriction enzyme recognition sequence and histidine His purification tag on the carrier. The secretion signal peptide aprE can guide the thermophilic neutral protease to enter a culture medium through a secretion channel of a bacillus subtilis cell membrane, and in the process, the secretion signal peptide aprE is excised by the signal peptidase on the cell membrane to obtain the recombinant thermophilic neutral protease without the secretion signal peptide sequence, and the amino acid sequence of the recombinant thermophilic neutral protease is shown as SEQ ID No.2. The secretory signal peptide aprE on the expression vector is further replaced by yoaW (the sequence is shown as SEQ ID No. 3), ykwD (the sequence is shown as SEQ ID No. 4), yurI (the sequence is shown as SEQ ID No. 5) and yrrS (the sequence is shown as SEQ ID No. 6), so that the secretory expression quantity of the thermophilic neutral protease in bacillus subtilis can be improved.
Serine proteases are typically expressed in the form of a precursor protein (pre-pro-protease) comprising a signal peptide sequence, an N-terminal propeptide and a mature enzyme. The function of the signal peptide is to ensure that the protein is released from the production cell into the cytosol or extracellular medium and cleaved from the precursor protein by the signal peptidase upon transport across the cell membrane to the outside of the cell. Proteins from which the signal peptide has been removed, known as zymogens (pro-proteases), are usually inactive and are treated to remove the N-terminal propeptide and become active mature enzymes, the cleavage resulting from self-digestion or autocatalytic cleavage by serine proteases. However, the thermophilic neutralizing protease of the invention was expressed in Bacillus subtilis as a pro-peptide sequence 48 h, the protease activity was detected in the supernatant, and SDS-PAGE electrophoresis detected at 45 kDa.
The invention relates to a recombinant thermophilic neutral protease, which is prepared by the following steps:
(1) The recombinant expression plasmid pET20b-Tth0724 is used as a template, a thermophilic neutral protease gene fragment (coding 21-434 aa) is obtained through PCR amplification, then the gene is inserted into a secretion signal peptide aprE downstream Sac I and BamH I site of an expression vector pBE-S to construct a recombinant expression plasmid of bacillus subtilis, the recombinant expression plasmid is screened by transforming E.coli DH5 alpha competent cells, the recombinant expression plasmid obtained by screening is transformed into bacillus subtilis competent RIK1285, and after the bacillus subtilis is subjected to shaking culture at 37 ℃ based on the LB liquid culture for 48 h, the thermophilic neutral protease is detected in a culture medium, so that the secretion signal peptide aprE can guide the secretory expression of the thermophilic neutral protease in the bacillus subtilis RIK 1285;
(2) In order to further increase the secretory expression amount of the thermophilic neutral protease in bacillus subtilis, the secretory expression amount can be achieved by optimizing a secretory signal peptide: cutting the recombinant expression plasmid obtained in the step (1) by Mlu I and Eco 52I, removing aprE secretion signal peptide on the recombinant expression plasmid, connecting with mixture SP DNA containing 173 bacillus subtilis secretion signal peptides, transforming E.coli DH5 alpha competent cells, coating on LB solid medium containing 100 mug/mL Amp, and culturing at 37 ℃ overnight; transferring all the obtained colonies into 5 mL LB liquid medium, shaking and culturing at 37 ℃ and 180 rpm for overnight, extracting recombinant expression plasmid mixture connected with different secretion signal peptides, electrically converting bacillus subtilis competent RIK1285, screening engineering bacteria with improved enzyme activity, and optimizing to obtain secretion signal peptides with improved secretion and expression of thermophilic neutral protease, wherein the secretion signal peptide yoaW is used for improving the secretion and expression of the thermophilic neutral protease most obviously, and the expression bacteria are used as the expression engineering bacteria of bacillus subtilis of the thermophilic neutral protease;
(3) Inoculating the expression engineering bacteria obtained in the step (2) to an LB liquid culture medium, carrying out shaking culture at 37 ℃ and 180 rpm for 48 h, centrifuging and collecting supernatant to obtain crude enzyme liquid, and carrying out ultrafiltration to obtain thermophilic neutral protease;
the secretion signal peptide optimized in the above step (2) includes yoaW, ykwD, yurI and yrrS. Compared with protease expressed by colibacillus, the thermophilic neutral protease of the invention mainly exists in the form of having a propeptide sequence, and only mature enzyme is obtained after expression and purification in colibacillus. The traditional subtilisin only has the activity of mature protein, and the zymogen with the propeptide sequence has no activity, but the thermophilic neutral protease provided by the invention has the propeptide sequence and has the proteolytic activity, and the protease does not need to be sheared, so that the production process is greatly simplified, and the production cost is reduced.
The second technical scheme of the invention: measurement of optimum temperature, optimum pH, thermal stability and pH stability of the thermophilic neutral protease catalytic reaction is carried out, and the specific operation is as follows;
(1) The optimal reaction temperature of the thermophilic neutral protease is explored by measuring the hydrolysis rate of the thermophilic neutral protease within the range of 65-95 ℃, and the optimal pH of the thermophilic neutral protease is measured within the range of pH 6.0-10.0;
(2) The thermophilic neutral protease was sampled at 75℃for different times and the residual activity of the thermophilic neutral protease was determined to investigate the thermostability of the thermophilic neutral protease.
The third technical scheme of the invention: use of a thermophilic neutralizing protease in the field of degrading proteins, comprising the following three aspects:
(1) Preparing heparin sodium by hydrolyzing the casing with thermophilic neutral protease: adding casing liquid in the small intestine of a 2 mL pig and 10-240U of neutral thermal protease into a 10 mL and 50 mmol/L phosphate buffer reaction system, and carrying out oscillation reaction at 75 ℃ and 120 rpm for 2 h to prepare heparin sodium;
(2) Preparing soybean bioactive peptide by hydrolyzing soybean meal with thermophilic neutral protease: crushing large-particle soybean meal by using a wall breaking machine, removing large particles by using a 100-mesh sieve, and continuously crushing for 10 min and fully grinding to obtain soybean meal powder; the enzymolysis system is 50 mL, 50 mmol/L phosphate buffer solution, contains bean pulp powder with the final concentration of 2.5% (m/v) and 100-1500U of thermophilic neutral protease, and performs oscillation reaction at 75 ℃ and 150 rpm for 3 h to prepare the soybean bioactive peptide;
(3) Use of a thermophilic neutralizing protein in a detergent: firstly, heat-treating an delicate detergent at 100 ℃ for 1 h, and inactivating the original enzyme preparation in the detergent; the treated detergent with the final concentration of 1% (v/v) and 10-240U of thermophilic neutral protease are contained in a 10 mL and 50 mmol/L phosphate buffer solution system, and the dirty cloth with pig blood is soaked in the liquid and is washed for 20 min at 60 ℃ under shaking at 120 rpm.
The thermophilic neutral protease is secreted and expressed by bacillus subtilis secretory expression engineering bacteria, is not limited to a specific expression vector, adopts eukaryotic or prokaryotic expression vectors as preferred expression vectors, and is further preferred to be a pBE-S vector; not limited to a specific secretion signal peptide, various secretion signal peptides of Bacillus subtilis may be used, and aprE, yoaW, ykwD, yurI and yrrS are further preferred; the expression vector is not limited to any particular host cell as long as it can express the above-mentioned expression vectors, such as bacillus subtilis RIK1285, BS168, WB600, WB800, etc., and in a preferred embodiment, bacillus subtilis RIK1285 strain is used.
All basic molecular biology procedures in the above technical schemes are referred to the "molecular cloning experimental guidelines" (third edition, scientific press, 2002).
The expression vectors pBE-S and bacillus subtilis host bacterium RIK2185 used in the invention are common vectors and host bacteria in the technical field and can be purchased from Bao Ri doctor Material technology (Beijing) company, the website of which: http:// www.takarabiomed.com.cn. May be purchased through a contact address given by the company or purchased through a proxy company for each province in the country.
Drawings
Fig. 1: secretory expression SDS-PAGE electrophoresis of thermophilic neutral protease; m is a standard molecular weight Marker, lane 1 is the secretion signal peptide aprE, lane 2 is the secretion signal peptide yoaW, and lane 3 is the secretion signal peptide ykwD. The arrow indicates the thermophilic neutral protease with a propeptide sequence, the molecular weight is 45 kDa, which indicates that the thermophilic neutral protease is secreted and expressed in the bacillus subtilis host RIK1285, and the secretory expression quantity of the thermophilic neutral protease is higher when the secretory signal peptide is yoaW.
Fig. 2: temperature-activity curve of thermophilic neutral protease; the abscissa is temperature and the ordinate is relative vigor. The activity of the thermophilic neutral protease is maintained to be more than 80% in the range of 65-95 ℃, and the maximum activity is shown at 80 ℃.
Fig. 3: a thermostability profile of a thermophilic neutralizing protease; the abscissa is time and the ordinate is residual vitality. The thermophilic neutral protease incubated at 75℃for 6 h reduced enzyme activity by only about 10%.
Fig. 4: pH-activity profile of thermophilic neutral protease; the abscissa is pH, the ordinate is relative activity, the thermophilic neutral protease maintains more than 80% of activity within the range of pH 6.0-8.0, and 60% of activity remains at pH 10.0.
Fig. 5: preparing heparin sodium titer chart by degrading casing liquid with thermophilic neutral protease; the abscissa indicates the type of protease and the ordinate indicates heparin sodium titer. The potency of heparin sodium produced by hydrolyzing casing liquid 2 h with thermophilic neutral protease is 10.8U/mL, and the effect is slightly weaker than that of commercial enzyme Bacillus subtilis neutral protease (Nanning Pang Bo bioengineering Co., ltd.) and better than that of P2000 alkaline protease (Jenergy bioengineering Co.).
Fig. 6: an antioxidant activity diagram of soybean polypeptide prepared by degrading soybean meal with thermophilic neutral protease; the abscissa indicates the protease species and the ordinate indicates the DDPH clearance. The effect of soybean polypeptide obtained by degrading soybean meal by thermophilic neutral protease for eliminating DPPH is obviously better than that of commercial enzymes of bacillus subtilis neutral protease (Nanning Pang Bo biological engineering Co., ltd.) and P2000 alkaline protease (Jenergic biological engineering Co., ltd.), which shows that the antioxidation activity is better.
Fig. 7: an antioxidant activity diagram of each component of soybean polypeptide prepared by degrading soybean meal by thermophilic neutral protease; the abscissa is the components of soy polypeptides of different molecular weights and the ordinate is DPPH clearance. After the soybean meal is degraded by the thermophilic neutral protease, the soybean polypeptide is divided into four components of more than 30 kDa, 10-30 kDa, 3-10 kDa and less than 3 kDa, wherein the component of less than 3 kDa has the best DPPH removing effect, namely the component has the best antioxidation effect.
Fig. 8: a map of compatibility of thermophilic neutralizing proteases with surfactants and bleaching agents; the abscissa is the type of surfactant and bleach, and the ordinate is the relative activity, and the control group was not added with surfactant and bleach, taking the enzyme activity of the control group as 100%. The compatibility of the thermophilic neutral protease with the surfactant and the bleaching agent added in the detergent is good, the relative activity of the enzyme is maintained above 90%, and the enzyme activity is improved by about 35% when 5% (v/v) Tween 20 and 80 exist, which indicates that the thermophilic neutral protease can stably exert the enzyme activity in the detergent.
Fig. 9: a map of the compatibility of a thermophilic neutral protease with commercial detergents; the abscissa is the brand of the detergent, the ordinate is the relative activity, and the control group is not added with the detergent, and the enzyme activity of the control group is 100%. The thermophilic neutral protease can keep more than 80% of enzyme activity in various detergents except the Bilang detergent, and the activity is improved by 6% in the delicate detergent.
Fig. 10: an effect diagram of thermophilic neutral protease for washing pig blood stains; 1: before washing, 2: an subtle detergent wash effect of heating 1 h at 100 ℃,3: washing effect of the addition of 240U thermophilic neutral protease to group 2 detergent. Indicating that the thermophilic neutral protease can well degrade hemoglobin and remove blood stains.
Detailed Description
Example 1: construction of engineering bacteria for secretory expression of thermophilic neutral protease bacillus subtilis and protein expression, comprising the following steps:
1. cloning of thermophilic neutral protease Gene
The recombinant plasmid pET20b-Tth0724 (Xie GQ, shao ZK, zong L, et al Heterologous expression and characterization of a noverlsubtilisin-like protease from a thermophilic Thermus thermophilus HB,International journal of biological macromolecules2019, 138:528-535) as template, and PCR amplification to obtain the thermophilic neutral protease gene, coding 414aa. The primer sequences for the thermophilic neutral protease are as follows:
an upstream primer: AGTAATGAGCTCCCCCAGACCCCA, restriction enzyme Sac I recognition site;
a downstream primer: GATTTGGGATCCGGGGAAGCAGTA, the restriction enzyme BamHI recognition site is located along the horizontal line.
And (3) PCR reaction: in a 100. Mu.L reaction system, 1. Mu.L pET20b-Tth0724 plasmid, 2. Mu.L upstream primer, 2. Mu.L downstream primer, 45. Mu.L ultra pure water, 50. Mu. L Premix PrimerSTART were contained Ⓡ HS enzyme cocktail (Bao Ri doctor Material technology (Beijing) company). Denaturation at 98℃for 10 s, annealing at 62℃for 5 s and elongation at 72℃for 85 s for 35 cycles per cycle.
The thermophilic neutral protease gene is recombined into an expression vector pBE-S by utilizing SacI and BamH I cleavage sites, and is connected to become a recombinant expression plasmid to transform competent cells of the escherichia coli. The recombinant plasmid construction process comprises the following steps: the thermophilic neutral protease PCR product and the expression vector pBE-S are respectively digested with restriction enzymes Sac I and BamH I, 5 mu L of restriction enzyme digestion buffer solution K and 2.5 mu L of the PCR product or the expression vector pBE-S are sequentially added into the digestion system, and the two restriction enzymes are uniformly mixed and reacted at 37 ℃ for 3 h. The resulting 5. Mu.L of the digested thermophilic neutral protease PCR product was mixed with 1. Mu.L of pBE-S vector fragment, 1. Mu.L of 10 XT 4 DNA ligase buffer, 1. Mu. L T4 DNA ligase and 2. Mu.L of sterile water and ligated in a water bath at 25℃for 4 h. The ligation mixture was transformed into E.coli DH 5. Alpha. Competent cells, plated on LB solid medium containing ampicillin at a final concentration of 100. Mu.g/mL, and cultured upside down at 37℃overnight. Single colony inoculation is selected, and the single colony inoculation is carried out on 5 mL LB liquid medium containing 100 mug/mL ampicillin, and shake culture is carried out at 37 ℃ and 180 rpm for overnight, and recombinant expression plasmid is extracted by using a plasmid extraction kit.
2. Expression of thermophilic neutral proteases
And (3) transforming the recombinant expression plasmid in the step (1) into bacillus subtilis RIK1285 competent cells to construct secretory expression engineering bacteria. Preparation of bacillus subtilis RIK1285 competent cells: inoculating bacillus subtilis RIK1285 into 5 mL of LB liquid medium, and culturing at 37 ℃ and 180 rpm under shaking for overnight; inoculating 2.5. 2.5 mL overnight culture solution into 40 mL sorbitol liquid medium (100 mL sorbitol liquid medium containing 1 g peptone, 0.5 g yeast extract, 1 g NaCl and 9 g sorbitol, sterilizing with 121 deg.C high pressure steam for 15 min), shaking culturing at 37deg.C and 180 rpm to OD 600 Centrifuging at 4000 rpm at 4deg.C for 10 min to collect thallus at 0.85-0.95; washing the cells with 40 mL electrotransformation solution (100 mL electrotransformation solution contains sorbitol 9 g, mannitol 9.25 g and glycerol 10 mL), centrifuging at 4000 rpm at 4deg.C for 10 min to collect cells, and repeating washing for 3 times; bacillus subtilis RIK1285 competent cells were prepared by resuspension of the cells with 1 mL electrotransformation solution. Adding 5 mu L of the recombinant expression plasmid in the step 1 into 100 mu L of competent cells, and transferring to precooled 0.2. 0.2 mm electricityIn a rotor, 2.5 ms was shocked by 2 kv in an electrotransfer apparatus, 1 mL resuscitating medium (100 mL resuscitating medium comprising peptone 1 g, yeast extract 0.5 g, naCl 1 g, sorbitol 9 g and mannitol 7 g, and sterilized by high-pressure steam at 121deg.C for 15 min) was immediately added, 2 h was cultured by shaking at 37deg.C and 180 rpm, spread on LB solid plate containing 50 μg/mL kanamycin, and cultured upside down overnight at 37deg.C. Single colonies are picked and inoculated into LB liquid medium containing 50 mug/mL kanamycin, the culture is carried out at 37 ℃ under 180 rpm shaking for 48 hours, the centrifugation is carried out at 12000 rpm for 15 minutes, the supernatant is collected, and the secretory expression of the thermophilic neutral protease in bacillus subtilis is identified and confirmed through SDS-PAGE electrophoresis, and the result is shown as lane 1 in the figure 1. The single colony verified by the steps can be used as engineering bacteria for expressing the thermophilic neutral protease, the secretion signal peptide aprE on the expression vector can guide the thermophilic neutral protease to be secreted and expressed in bacillus subtilis into a culture medium, the signal peptide aprE is excised by the signal peptidase on a cell membrane when passing through a secretion channel, and the thermophilic neutral protease without a secretion signal peptide sequence is obtained, and the amino acid sequence is shown as SEQ ID No.2.
3. Optimization of Signal peptides
The amino acid composition and the property of the secretion signal peptide are important factors influencing different secretion expression amounts of exogenous proteins in bacillus subtilis, and in order to further improve the secretion expression amount of the thermophilic neutral protease in bacillus subtilis, the secretion signal peptide aprE of the recombinant expression plasmid in the step 1 is replaced by other bacillus subtilis signal peptides, and the expression engineering bacteria with improved secretion expression amount of the thermophilic neutral protease are screened. The recombinant expression plasmid of step 1 was digested with restriction enzymes Mlu I and Eco 52I at 37℃for 3 h, the aprE secretion signal peptide on the recombinant expression plasmid was removed, the plasmid DNA fragment from which the signal peptide was removed was purified using a DNA recovery kit, 4. Mu.L of the plasmid DNA fragment, 1.5. Mu.L of SP DNA mixture containing 173 kinds of Bacillus subtilis secretion signal peptides, 2. Mu.L of 5 Xligase In-fusion HD enzyme premix and 2.5. Mu.L of ultrapure water were taken, and the mixture was ligated at 50℃for 15 minutes to transform E.coli HST08 competent cells, and the mixture was spread on 5 mL LB solid medium containing 100. Mu.g/mL ampicillin, and cultured upside down at 37℃overnight. All colonies on the plates were transferred to 5 mL LB liquid medium containing 100. Mu.g/mL ampicillin, plasmids were extracted after overnight incubation at 37℃and transformed into competent cells of Bacillus subtilis RIK1285, and engineering bacteria with improved enzyme activity were selected. The signal peptides which are verified by DNA sequencing to improve the secretory expression quantity of the thermophilic neutral protease comprise yoaW, ykwD, yurI and yrrS (the secretory signal peptide coding genes are upstream of the target genes, fusion proteins with the secretory signal peptide are expressed, the secretory signal peptide guides the secretory expression of the target protein through the cell membrane of a host cell and is cut off when passing through the cell membrane channel, so that the obtained protein is only the target protein of SEQ ID No. 2), wherein the secretory signal peptides yoaW and ykwD are more beneficial to the secretory expression of the thermophilic neutral protease, and the result is shown in lanes 2 and 3 in FIG. 1. The secretion signal peptide sequence which can enable the thermophilic neutral protease to carry out secretory expression in bacillus subtilis is shown in SEQ ID No.3-6.
In this example, the bacillus subtilis strain used is RIK1285, but not limited to RIK1285, and the bacillus subtilis strain used for expression of the recombinant plasmid also comprises host cells such as BS168, WB600 and WB 800.
Example 2: optimum temperature, optimum pH and thermostability of thermophilic neutral protease
1. Optimum reaction temperature and thermal stability
The activity of the thermophilic neutral protease is measured within the range of 65-95 ℃, the relative activity of the enzyme is plotted against the temperature, as shown in figure 2, the optimal reaction temperature of the thermophilic neutral protease is 80 ℃, and the activity of the enzyme is maintained to be more than 80% within the range of 65-95 ℃.
Detection of protease activity: protease activity was determined using azocasein as substrate. Preparation of azo-casein substrate for this assay: 0.5. 0.5 g azocasein was dissolved in 100 mL, 0.2 mol/L phosphate buffer (pH 7.0) to prepare a substrate solution containing 0.5% azocasein. A substrate solution of 0.1. 0.1 mL was incubated at 75℃for 5 min, followed by addition of an enzyme solution of 0.3. 0.3 mL and reaction at 75℃for 30 min. Then, 0.4 mL of a 0.6mol/L trichloroacetic acid (TCA) solution was added to terminate the reaction, the mixture was centrifuged at 5000 rpm for 5 minutes, and the supernatant was collected and absorbance was measured at 335 and nm by a UV-1601 spectrophotometer. The control group was treated identically with 0.6mol/L TCA prior to the addition of the enzyme solution. Under the above reaction conditions, the enzyme activity unit is defined as the amount of enzyme required to hydrolyze azocasein for 1 min with a change in absorbance value of 0.001, which is 1 enzyme activity unit.
The residual activities of the thermoneutral proteases were measured by the above-mentioned protease activity measurement method by incubating the thermoneutral proteases at a concentration of 0.1. 0.1 mg/mL at 75℃for various periods of time. The result of the heat stability of the thermophilic neutral protease is shown in figure 3, and the residual activity of the thermophilic neutral protease after being incubated at 75 ℃ for 6 h is more than 90%, which indicates that the thermophilic neutral protease has very good heat stability.
2. Optimal reaction pH
The activity of the thermophilic neutral protease is measured at 75 ℃ within the pH range of 6.0-10.5, and the buffer solution is 50 mmol/L Na 2 HPO 4 -NaH 2 PO 4 Buffer solution (pH 6.0-8.0), tris-HCl buffer solution (pH 8.0-9.0), glycine-NaOH buffer solution (pH 9.0-11.0). The activity-pH curve of the thermophilic neutral protease is shown in fig. 4, the thermophilic neutral protease can effectively catalyze the hydrolysis of casein at the pH of 6.0-10.0, the optimal pH is 7.0, and the residual enzyme activity is more than 80% within the pH range of 6.0-8.0.
Example 3: application of thermophilic neutral protease in degrading protein
1. Heparin sodium produced by degrading casing liquid with thermophilic neutral protease
The reaction system of 10 mL contains 50 mmol/L phosphate buffer solution (pH 7.0), casing solution of 2 mL pig small intestine and 240U thermophilic neutral protease (amino acid sequence is shown as SEQ ID No. 2), and the reaction system is subjected to shaking reaction at 75 ℃ and 120 rpm for 0.5 h and 2 h, and the sodium heparin content is detected by using a azure A kit for sampling. The control group was not added with enzyme and the other conditions were identical to the experimental group. Commercial enzyme neutral protease and P2000 alkaline protease are compared, wherein the reaction system and the enzyme dosage of the neutral protease are the same as those of the thermophilic neutral protease, and the neutral protease reacts at 40 ℃; the buffer used for P2000 was glycine-NaOH (pH 10.0) at 50 mmol/L and reacted at 50 ℃. The results of the heparin sodium titers plotted against the three proteases are shown in FIG. 5.
2. Production of soybean polypeptide by degrading soybean meal with thermophilic neutral protease
The reaction of degrading soybean meal by thermophilic neutral protease to produce soybean polypeptide: pulverizing large-particle soybean meal with a wall breaking machine, sieving with a 100 mesh sieve to remove large particles, and continuously pulverizing for 10 min to obtain soybean meal powder. The enzymolysis system is 50 mL phosphate buffer (pH 7.0), contains soybean meal powder with a final concentration of 2.5% (m/v) and 1500U thermophilic neutral protease (amino acid sequence shown as SEQ ID No. 2), and is subjected to oscillation reaction at 75deg.C and 150 rpm for 3 h. Antioxidant activity of enzymatic hydrolysis to produce soybean polypeptide by detecting the clearance rate of the enzymatic hydrolysis product to DPPH (2, 2-Diphenyl-1-picrylhydrazyl, 2-Diphenyl-1-picrylhydrazyl) free radical, the following specific reactions are carried out: 200 mu L of enzymolysis product is taken, 400 mu L of 0.1 mmol/L DPPH solution is added, the reaction is carried out at room temperature for 30 min in a dark place, and the absorbance value of 517 and nm is detected. The control group was identical to the experimental group except that no enzyme was added. Commercial enzyme neutral protease and P2000 alkaline protease are compared, wherein the reaction system and the enzyme dosage of the neutral protease are the same as those of the thermophilic neutral protease, and the neutral protease reacts at 40 ℃; the buffer used for P2000 was glycine-NaOH (pH 10.0) at 50 mmol/L and reacted at 50 ℃. The results of the DDPH patterns for the three enzymatic hydrolysis products are shown in FIG. 6, and show that the soybean polypeptide produced by degrading soybean meal by thermophilic neutral protease has the strongest antioxidant activity.
Centrifuging the product of degrading soybean meal by using the thermophilic neutral protease at 4000 rpm for 10 min by using an ultrafiltration tube with a molecular weight cut-off of 30 kDa, wherein the supernatant is a polypeptide component with a molecular weight of >30 kDa; centrifuging the filtrate with ultrafiltration tube with molecular weight cut-off of 10 kDa, and collecting supernatant with 10-30 kDa polypeptide component; and centrifuging the filtrate by using an ultrafiltration tube with a molecular weight cutoff of 3 kDa, wherein the supernatant is a 3-10 kDa polypeptide component, and the filtrate is a <3 kDa polypeptide component. The clearance of DDPH from the four fractions was determined using the method described above and the antioxidant activity of the different polypeptide fractions was analyzed, as shown in fig. 7, with the antioxidant activity of the <3 kDa polypeptide fraction being strongest.
3. Use of thermophilic neutral proteases in detergents
(1) Compatibility of thermophilic neutral proteases with surfactants and bleaching agents
Surfactant and bleaching agent are added into the detergent to enhance the washing effect, and compatibility experiment of the thermophilic neutral protease and the surfactant and the bleaching agent: 1% or 5% (v/v) of surfactants SDS, DMSO, tween 20, tween 80 and triton X-100, bleaching agents such as hydrogen peroxide and sodium perborate, were added to the thermophilic neutral protease (amino acid sequence shown in SEQ ID No. 2), respectively, and the mixture was allowed to stand at room temperature for 0.5. 0.5 h to examine the residual activity of the thermophilic neutral protease, and the result is shown in FIG. 8. The method for measuring the enzyme activity is shown in example 1.
(2) Compatibility of thermophilic neutral protease with detergent
Six liquid detergents of the delicate, super-energy, blue moon, white, eliminating stains and green waves are respectively heat treated at 100 ℃ for 1 h, and the original enzyme preparation in the detergent is thoroughly inactivated. The residual activity of the thermophilic neutral protease was measured by adding 1% (v/v) of the treated detergent to the thermophilic neutral protease, mixing the mixture and standing the mixture at room temperature for 0.5. 0.5 h, and the result is shown in FIG. 9. The method for measuring the enzyme activity is shown in example 1.
(3) Effects of thermophilic neutral protease on washing blood stains
The white cloth was cut into square pieces of 3 cm ×3 cm for use. Taking 300 mu L of pig blood, placing 100 mu L of pig blood at the center of a white cloth block each time, placing the pig blood in a 37 ℃ incubator, standing for 20 min, drying, repeating for three times, and preparing blood stain cloth. The delicate detergent is heat treated at 100 ℃ for 1 h, and the original enzyme preparation in the detergent is inactivated. The treated detergent was immersed in 10 mL (v/v) phosphate buffer (pH 7.0) at a final concentration of 1% (v/v) and 240U thermophilic neutral protease (amino acid sequence shown in SEQ ID No. 2) to wash the blood stain cloth at 60℃and 120 rpm for 20 minutes, and the washing effect was observed, and the result is shown in FIG. 10. The control group was the same as the experimental group except that the thermophilic protease was not added.
The present disclosure is believed to be of the best use of the invention by those skilled in the art. Accordingly, the foregoing preferred embodiments should be construed as merely illustrative, and not limitative of the remainder of the disclosure in any way whatsoever.
<110> Jilin university
<120> a recombinant thermophilic neutral protease and its use for degrading proteins
<160> 6
<170> PatentIn version 3.5
<210> 1
<211> 1407
<212> DNA
<213> Thermus thermophilus HB8
<220>
<221> CDS
<222> (1)..(1407)
<220>
<221> aprE SP
<222> (1)..(87)
<220>
<221> thermophilic neutral protease
<222> (88)..(1407)
<400> 1
atg aga agc aaa aaa ttg tgg atc agc ttg ttg ttt gcg tta acg tta 48
Met Arg Ser Lys Lys Leu Trp Ile Ser Leu Leu Phe Ala Leu Thr Leu
1 5 10 15
atc ttt acg atg gcg ttc agc aac atg tct gtg cag gct gcg gcc ggt 96
Ile Phe Thr Met Ala Phe Ser Asn Met Ser Val Gln Ala Ala Ala Gly
20 25 30
gca cat atg gag ctc ccc cag acc cca ccg ccg ccc gtg aac ccc gcc 144
Ala His Met Glu Leu Pro Gln Thr Pro Pro Pro Pro Val Asn Pro Ala
35 40 45
gag tgc ccg gta ggt ccc ctg cgg gtg cag agc ctg gat gct cct tct 192
Glu Cys Pro Val Gly Pro Leu Arg Val Gln Ser Leu Asp Ala Pro Ser
50 55 60
aag ctg cac ggt ttg gga agc ttt aaa ggg gag ttc gtt ccg gga gaa 240
Lys Leu His Gly Leu Gly Ser Phe Lys Gly Glu Phe Val Pro Gly Glu
65 70 75 80
ctc att gta gtg ccc aaa cca ggt ctt tcc ctt cag agc ttg cgg gcc 288
Leu Ile Val Val Pro Lys Pro Gly Leu Ser Leu Gln Ser Leu Arg Ala
85 90 95
tca gga gta gag ccc cag gcc cag ctc gcc ctg gac gta atc aag gtg 336
Ser Gly Val Glu Pro Gln Ala Gln Leu Ala Leu Asp Val Ile Lys Val
100 105 110
aag gtt ccc cat ggg gag gag aaa gtc cga gcg gaa gct ctt ttg cgg 384
Lys Val Pro His Gly Glu Glu Lys Val Arg Ala Glu Ala Leu Leu Arg
115 120 125
gcg ggt gct cag tat gtc cag ccc aac tac gtt tac cgg cct ttg cgg 432
Ala Gly Ala Gln Tyr Val Gln Pro Asn Tyr Val Tyr Arg Pro Leu Arg
130 135 140
gct ccg aat gac ctc tat tac ccc gat caa agc gcc tac ttg aat cgg 480
Ala Pro Asn Asp Leu Tyr Tyr Pro Asp Gln Ser Ala Tyr Leu Asn Arg
145 150 155 160
ttg gtg cgc tta gaa agc gct tgg gac ttc agc aca ggc agg gga tgc 528
Leu Val Arg Leu Glu Ser Ala Trp Asp Phe Ser Thr Gly Arg Gly Cys
165 170 175
ccg ccc ctt gtg gcc gtg cta gac acg gga gtt ctt gcc cac gag gac 576
Pro Pro Leu Val Ala Val Leu Asp Thr Gly Val Leu Ala His Glu Asp
180 185 190
ttt cag gcc agc aag tac ctc ccc gcc ggg gtt aac ctg gac gtg gct 624
Phe Gln Ala Ser Lys Tyr Leu Pro Ala Gly Val Asn Leu Asp Val Ala
195 200 205
gac gga gat gcc aat ccc acg gac gac tcg gct ccc aac aat tgg ggg 672
Asp Gly Asp Ala Asn Pro Thr Asp Asp Ser Ala Pro Asn Asn Trp Gly
210 215 220
cat ggt tta gag gtg gcc tcg gtc ttg ggg gcg gat acc aac aac tct 720
His Gly Leu Glu Val Ala Ser Val Leu Gly Ala Asp Thr Asn Asn Ser
225 230 235 240
aag gga ata gca gga act acc tgg ggt gga tac gtt gtt cca atc aag 768
Lys Gly Ile Ala Gly Thr Thr Trp Gly Gly Tyr Val Val Pro Ile Lys
245 250 255
gtt ttc tac cgg ggt ggt gga gcc acg tat gaa acc ctt ttc aag ggg 816
Val Phe Tyr Arg Gly Gly Gly Ala Thr Tyr Glu Thr Leu Phe Lys Gly
260 265 270
gtt cgg tta gcc cgc caa ctg ggg gcc cag gtc atc aac att tcg ctg 864
Val Arg Leu Ala Arg Gln Leu Gly Ala Gln Val Ile Asn Ile Ser Leu
275 280 285
ggg ggt aac gac tat gac gag gtt ctg gat gag gag ctg gcc cgg gct 912
Gly Gly Asn Asp Tyr Asp Glu Val Leu Asp Glu Glu Leu Ala Arg Ala
290 295 300
cgg aac gag ggg agg gtt att gta gct gcg gcg gga aac tac gag acc 960
Arg Asn Glu Gly Arg Val Ile Val Ala Ala Ala Gly Asn Tyr Glu Thr
305 310 315 320
ggg aat ggg gga ccg gtt atg ttc cct gcc agc agc ccc aac act ctc 1008
Gly Asn Gly Gly Pro Val Met Phe Pro Ala Ser Ser Pro Asn Thr Leu
325 330 335
gct gtg ggt gcg gta gat ctc ctt aaa agg cgg gcg aat ttt tcg gcc 1056
Ala Val Gly Ala Val Asp Leu Leu Lys Arg Arg Ala Asn Phe Ser Ala
340 345 350
tat ggc ccc gag ctt gac cta atg gct cca ggg gtg gag gtt ttg gcg 1104
Tyr Gly Pro Glu Leu Asp Leu Met Ala Pro Gly Val Glu Val Leu Ala
355 360 365
gca ggc cct tca ggc aac tat cgc ttt gtg agc ggc acc tct ttg gct 1152
Ala Gly Pro Ser Gly Asn Tyr Arg Phe Val Ser Gly Thr Ser Leu Ala
370 375 380
agc ccc atc gtg gcc ggg gtg gtg gcc ctc tac atg agc aag tac gcc 1200
Ser Pro Ile Val Ala Gly Val Val Ala Leu Tyr Met Ser Lys Tyr Ala
385 390 395 400
agc gag cgg aag gcg tgg cct agc ccg gac cag gtc tac caa tgc ctc 1248
Ser Glu Arg Lys Ala Trp Pro Ser Pro Asp Gln Val Tyr Gln Cys Leu
405 410 415
atc aac acc gcc gag gac cta ggg cct tcc ggt tgg gac ccg gaa tac 1296
Ile Asn Thr Ala Glu Asp Leu Gly Pro Ser Gly Trp Asp Pro Glu Tyr
420 425 430
ggc ttc ggc ctg gtc cgg gcc gac cgg gcg atg acg gac acc acc tac 1344
Gly Phe Gly Leu Val Arg Ala Asp Arg Ala Met Thr Asp Thr Thr Tyr
435 440 445
tgc ttc ccc gga tcc gaa ttc aag ctt gtc gac ctg cag tct cat cac 1392
Cys Phe Pro Gly Ser Glu Phe Lys Leu Val Asp Leu Gln Ser His His
450 455 460
cat cat cac cac taa 1407
His His His His
465
<210> 2
<211> 439
<212> PRT
<213> Thermus thermophilus HB8
<400> 2
Ala Ala Gly Ala His Met Glu Leu Pro Gln Thr Pro Pro Pro Pro Val
1 5 10 15
Asn Pro Ala Glu Cys Pro Val Gly Pro Leu Arg Val Gln Ser Leu Asp
20 25 30
Ala Pro Ser Lys Leu His Gly Leu Gly Ser Phe Lys Gly Glu Phe Val
35 40 45
Pro Gly Glu Leu Ile Val Val Pro Lys Pro Gly Leu Ser Leu Gln Ser
50 55 60
Leu Arg Ala Ser Gly Val Glu Pro Gln Ala Gln Leu Ala Leu Asp Val
65 70 75 80
Ile Lys Val Lys Val Pro His Gly Glu Glu Lys Val Arg Ala Glu Ala
85 90 95
Leu Leu Arg Ala Gly Ala Gln Tyr Val Gln Pro Asn Tyr Val Tyr Arg
100 105 110
Pro Leu Arg Ala Pro Asn Asp Leu Tyr Tyr Pro Asp Gln Ser Ala Tyr
115 120 125
Leu Asn Arg Leu Val Arg Leu Glu Ser Ala Trp Asp Phe Ser Thr Gly
130 135 140
Arg Gly Cys Pro Pro Leu Val Ala Val Leu Asp Thr Gly Val Leu Ala
145 150 155 160
His Glu Asp Phe Gln Ala Ser Lys Tyr Leu Pro Ala Gly Val Asn Leu
165 170 175
Asp Val Ala Asp Gly Asp Ala Asn Pro Thr Asp Asp Ser Ala Pro Asn
180 185 190
Asn Trp Gly His Gly Leu Glu Val Ala Ser Val Leu Gly Ala Asp Thr
195 200 205
Asn Asn Ser Lys Gly Ile Ala Gly Thr Thr Trp Gly Gly Tyr Val Val
210 215 220
Pro Ile Lys Val Phe Tyr Arg Gly Gly Gly Ala Thr Tyr Glu Thr Leu
225 230 235 240
Phe Lys Gly Val Arg Leu Ala Arg Gln Leu Gly Ala Gln Val Ile Asn
245 250 255
Ile Ser Leu Gly Gly Asn Asp Tyr Asp Glu Val Leu Asp Glu Glu Leu
260 265 270
Ala Arg Ala Arg Asn Glu Gly Arg Val Ile Val Ala Ala Ala Gly Asn
275 280 285
Tyr Glu Thr Gly Asn Gly Gly Pro Val Met Phe Pro Ala Ser Ser Pro
290 295 300
Asn Thr Leu Ala Val Gly Ala Val Asp Leu Leu Lys Arg Arg Ala Asn
305 310 315 320
Phe Ser Ala Tyr Gly Pro Glu Leu Asp Leu Met Ala Pro Gly Val Glu
325 330 335
Val Leu Ala Ala Gly Pro Ser Gly Asn Tyr Arg Phe Val Ser Gly Thr
340 345 350
Ser Leu Ala Ser Pro Ile Val Ala Gly Val Val Ala Leu Tyr Met Ser
355 360 365
Lys Tyr Ala Ser Glu Arg Lys Ala Trp Pro Ser Pro Asp Gln Val Tyr
370 375 380
Gln Cys Leu Ile Asn Thr Ala Glu Asp Leu Gly Pro Ser Gly Trp Asp
385 390 395 400
Pro Glu Tyr Gly Phe Gly Leu Val Arg Ala Asp Arg Ala Met Thr Asp
405 410 415
Thr Thr Tyr Cys Phe Pro Gly Ser Glu Phe Lys Leu Val Asp Leu Gln
420 425 430
Ser His His His His His His
435
<210> 3
<211> 1392
<212> DNA
<213> Thermus thermophilus HB8
<220>
<221> CDS
<222> (1)..(1392)
<220>
<221> yoaW SP
<222> (1)..(72)
<220>
<221> thermophilic neutral protease
<222> (73)..(1392)
<400> 3
atg aaa aag atg ttg atg tta gct ttt aca ttt ctt ttg gct ttg act 48
Met Lys Lys Met Leu Met Leu Ala Phe Thr Phe Leu Leu Ala Leu Thr
1 5 10 15
atc cat gta ggg gaa gct tcg gct gcg gcc ggt gca cat atg gag ctc 96
Ile His Val Gly Glu Ala Ser Ala Ala Ala Gly Ala His Met Glu Leu
20 25 30
ccc cag acc cca ccg ccg ccc gtg aac ccc gcc gag tgc ccg gta ggt 144
Pro Gln Thr Pro Pro Pro Pro Val Asn Pro Ala Glu Cys Pro Val Gly
35 40 45
ccc ctg cgg gtg cag agc ctg gat gct cct tct aag ctg cac ggt ttg 192
Pro Leu Arg Val Gln Ser Leu Asp Ala Pro Ser Lys Leu His Gly Leu
50 55 60
gga agc ttt aaa ggg gag ttc gtt ccg gga gaa ctc att gta gtg ccc 240
Gly Ser Phe Lys Gly Glu Phe Val Pro Gly Glu Leu Ile Val Val Pro
65 70 75 80
aaa cca ggt ctt tcc ctt cag agc ttg cgg gcc tca gga gta gag ccc 288
Lys Pro Gly Leu Ser Leu Gln Ser Leu Arg Ala Ser Gly Val Glu Pro
85 90 95
cag gcc cag ctc gcc ctg gac gta atc aag gtg aag gtt ccc cat ggg 336
Gln Ala Gln Leu Ala Leu Asp Val Ile Lys Val Lys Val Pro His Gly
100 105 110
gag gag aaa gtc cga gcg gaa gct ctt ttg cgg gcg ggt gct cag tat 384
Glu Glu Lys Val Arg Ala Glu Ala Leu Leu Arg Ala Gly Ala Gln Tyr
115 120 125
gtc cag ccc aac tac gtt tac cgg cct ttg cgg gct ccg aat gac ctc 432
Val Gln Pro Asn Tyr Val Tyr Arg Pro Leu Arg Ala Pro Asn Asp Leu
130 135 140
tat tac ccc gat caa agc gcc tac ttg aat cgg ttg gtg cgc tta gaa 480
Tyr Tyr Pro Asp Gln Ser Ala Tyr Leu Asn Arg Leu Val Arg Leu Glu
145 150 155 160
agc gct tgg gac ttc agc aca ggc agg gga tgc ccg ccc ctt gtg gcc 528
Ser Ala Trp Asp Phe Ser Thr Gly Arg Gly Cys Pro Pro Leu Val Ala
165 170 175
gtg cta gac acg gga gtt ctt gcc cac gag gac ttt cag gcc agc aag 576
Val Leu Asp Thr Gly Val Leu Ala His Glu Asp Phe Gln Ala Ser Lys
180 185 190
tac ctc ccc gcc ggg gtt aac ctg gac gtg gct gac gga gat gcc aat 624
Tyr Leu Pro Ala Gly Val Asn Leu Asp Val Ala Asp Gly Asp Ala Asn
195 200 205
ccc acg gac gac tcg gct ccc aac aat tgg ggg cat ggt tta gag gtg 672
Pro Thr Asp Asp Ser Ala Pro Asn Asn Trp Gly His Gly Leu Glu Val
210 215 220
gcc tcg gtc ttg ggg gcg gat acc aac aac tct aag gga ata gca gga 720
Ala Ser Val Leu Gly Ala Asp Thr Asn Asn Ser Lys Gly Ile Ala Gly
225 230 235 240
act acc tgg ggt gga tac gtt gtt cca atc aag gtt ttc tac cgg ggt 768
Thr Thr Trp Gly Gly Tyr Val Val Pro Ile Lys Val Phe Tyr Arg Gly
245 250 255
ggt gga gcc acg tat gaa acc ctt ttc aag ggg gtt cgg tta gcc cgc 816
Gly Gly Ala Thr Tyr Glu Thr Leu Phe Lys Gly Val Arg Leu Ala Arg
260 265 270
caa ctg ggg gcc cag gtc atc aac att tcg ctg ggg ggt aac gac tat 864
Gln Leu Gly Ala Gln Val Ile Asn Ile Ser Leu Gly Gly Asn Asp Tyr
275 280 285
gac gag gtt ctg gat gag gag ctg gcc cgg gct cgg aac gag ggg agg 912
Asp Glu Val Leu Asp Glu Glu Leu Ala Arg Ala Arg Asn Glu Gly Arg
290 295 300
gtt att gta gct gcg gcg gga aac tac gag acc ggg aat ggg gga ccg 960
Val Ile Val Ala Ala Ala Gly Asn Tyr Glu Thr Gly Asn Gly Gly Pro
305 310 315 320
gtt atg ttc cct gcc agc agc ccc aac act ctc gct gtg ggt gcg gta 1008
Val Met Phe Pro Ala Ser Ser Pro Asn Thr Leu Ala Val Gly Ala Val
325 330 335
gat ctc ctt aaa agg cgg gcg aat ttt tcg gcc tat ggc ccc gag ctt 1056
Asp Leu Leu Lys Arg Arg Ala Asn Phe Ser Ala Tyr Gly Pro Glu Leu
340 345 350
gac cta atg gct cca ggg gtg gag gtt ttg gcg gca ggc cct tca ggc 1104
Asp Leu Met Ala Pro Gly Val Glu Val Leu Ala Ala Gly Pro Ser Gly
355 360 365
aac tat cgc ttt gtg agc ggc acc tct ttg gct agc ccc atc gtg gcc 1152
Asn Tyr Arg Phe Val Ser Gly Thr Ser Leu Ala Ser Pro Ile Val Ala
370 375 380
ggg gtg gtg gcc ctc tac atg agc aag tac gcc agc gag cgg aag gcg 1200
Gly Val Val Ala Leu Tyr Met Ser Lys Tyr Ala Ser Glu Arg Lys Ala
385 390 395 400
tgg cct agc ccg gac cag gtc tac caa tgc ctc atc aac acc gcc gag 1248
Trp Pro Ser Pro Asp Gln Val Tyr Gln Cys Leu Ile Asn Thr Ala Glu
405 410 415
gac cta ggg cct tcc ggt tgg gac ccg gaa tac ggc ttc ggc ctg gtc 1296
Asp Leu Gly Pro Ser Gly Trp Asp Pro Glu Tyr Gly Phe Gly Leu Val
420 425 430
cgg gcc gac cgg gcg atg acg gac acc acc tac tgc ttc ccc gga tcc 1344
Arg Ala Asp Arg Ala Met Thr Asp Thr Thr Tyr Cys Phe Pro Gly Ser
435 440 445
gaa ttc aag ctt gtc gac ctg cag tct cat cac cat cat cac cac taa 1392
Glu Phe Lys Leu Val Asp Leu Gln Ser His His His His His His
450 455 460
<210> 4
<211> 1398
<212> DNA
<213> Thermus thermophilus HB8
<220>
<221> CDS
<222> (1)..(1398)
<220>
<221> ykwD SP
<222> (1)..(78)
<220>
<221> thermophilic neutral protease
<222> (79)..(1398)
<400> 4
atg aag aaa gca ttt att tta tct gct gcc gct gcg gtt gga tta ttc 48
Met Lys Lys Ala Phe Ile Leu Ser Ala Ala Ala Ala Val Gly Leu Phe
1 5 10 15
aca ttc ggg ggc gta cag caa gca tca gcg gcg gcc ggt gca cat atg 96
Thr Phe Gly Gly Val Gln Gln Ala Ser Ala Ala Ala Gly Ala His Met
20 25 30
gag ctc ccc cag acc cca ccg ccg ccc gtg aac ccc gcc gag tgc ccg 144
Glu Leu Pro Gln Thr Pro Pro Pro Pro Val Asn Pro Ala Glu Cys Pro
35 40 45
gta ggt ccc ctg cgg gtg cag agc ctg gat gct cct tct aag ctg cac 192
Val Gly Pro Leu Arg Val Gln Ser Leu Asp Ala Pro Ser Lys Leu His
50 55 60
ggt ttg gga agc ttt aaa ggg gag ttc gtt ccg gga gaa ctc att gta 240
Gly Leu Gly Ser Phe Lys Gly Glu Phe Val Pro Gly Glu Leu Ile Val
65 70 75 80
gtg ccc aaa cca ggt ctt tcc ctt cag agc ttg cgg gcc tca gga gta 288
Val Pro Lys Pro Gly Leu Ser Leu Gln Ser Leu Arg Ala Ser Gly Val
85 90 95
gag ccc cag gcc cag ctc gcc ctg gac gta atc aag gtg aag gtt ccc 336
Glu Pro Gln Ala Gln Leu Ala Leu Asp Val Ile Lys Val Lys Val Pro
100 105 110
cat ggg gag gag aaa gtc cga gcg gaa gct ctt ttg cgg gcg ggt gct 384
His Gly Glu Glu Lys Val Arg Ala Glu Ala Leu Leu Arg Ala Gly Ala
115 120 125
cag tat gtc cag ccc aac tac gtt tac cgg cct ttg cgg gct ccg aat 432
Gln Tyr Val Gln Pro Asn Tyr Val Tyr Arg Pro Leu Arg Ala Pro Asn
130 135 140
gac ctc tat tac ccc gat caa agc gcc tac ttg aat cgg ttg gtg cgc 480
Asp Leu Tyr Tyr Pro Asp Gln Ser Ala Tyr Leu Asn Arg Leu Val Arg
145 150 155 160
tta gaa agc gct tgg gac ttc agc aca ggc agg gga tgc ccg ccc ctt 528
Leu Glu Ser Ala Trp Asp Phe Ser Thr Gly Arg Gly Cys Pro Pro Leu
165 170 175
gtg gcc gtg cta gac acg gga gtt ctt gcc cac gag gac ttt cag gcc 576
Val Ala Val Leu Asp Thr Gly Val Leu Ala His Glu Asp Phe Gln Ala
180 185 190
agc aag tac ctc ccc gcc ggg gtt aac ctg gac gtg gct gac gga gat 624
Ser Lys Tyr Leu Pro Ala Gly Val Asn Leu Asp Val Ala Asp Gly Asp
195 200 205
gcc aat ccc acg gac gac tcg gct ccc aac aat tgg ggg cat ggt tta 672
Ala Asn Pro Thr Asp Asp Ser Ala Pro Asn Asn Trp Gly His Gly Leu
210 215 220
gag gtg gcc tcg gtc ttg ggg gcg gat acc aac aac tct aag gga ata 720
Glu Val Ala Ser Val Leu Gly Ala Asp Thr Asn Asn Ser Lys Gly Ile
225 230 235 240
gca gga act acc tgg ggt gga tac gtt gtt cca atc aag gtt ttc tac 768
Ala Gly Thr Thr Trp Gly Gly Tyr Val Val Pro Ile Lys Val Phe Tyr
245 250 255
cgg ggt ggt gga gcc acg tat gaa acc ctt ttc aag ggg gtt cgg tta 816
Arg Gly Gly Gly Ala Thr Tyr Glu Thr Leu Phe Lys Gly Val Arg Leu
260 265 270
gcc cgc caa ctg ggg gcc cag gtc atc aac att tcg ctg ggg ggt aac 864
Ala Arg Gln Leu Gly Ala Gln Val Ile Asn Ile Ser Leu Gly Gly Asn
275 280 285
gac tat gac gag gtt ctg gat gag gag ctg gcc cgg gct cgg aac gag 912
Asp Tyr Asp Glu Val Leu Asp Glu Glu Leu Ala Arg Ala Arg Asn Glu
290 295 300
ggg agg gtt att gta gct gcg gcg gga aac tac gag acc ggg aat ggg 960
Gly Arg Val Ile Val Ala Ala Ala Gly Asn Tyr Glu Thr Gly Asn Gly
305 310 315 320
gga ccg gtt atg ttc cct gcc agc agc ccc aac act ctc gct gtg ggt 1008
Gly Pro Val Met Phe Pro Ala Ser Ser Pro Asn Thr Leu Ala Val Gly
325 330 335
gcg gta gat ctc ctt aaa agg cgg gcg aat ttt tcg gcc tat ggc ccc 1056
Ala Val Asp Leu Leu Lys Arg Arg Ala Asn Phe Ser Ala Tyr Gly Pro
340 345 350
gag ctt gac cta atg gct cca ggg gtg gag gtt ttg gcg gca ggc cct 1104
Glu Leu Asp Leu Met Ala Pro Gly Val Glu Val Leu Ala Ala Gly Pro
355 360 365
tca ggc aac tat cgc ttt gtg agc ggc acc tct ttg gct agc ccc atc 1152
Ser Gly Asn Tyr Arg Phe Val Ser Gly Thr Ser Leu Ala Ser Pro Ile
370 375 380
gtg gcc ggg gtg gtg gcc ctc tac atg agc aag tac gcc agc gag cgg 1200
Val Ala Gly Val Val Ala Leu Tyr Met Ser Lys Tyr Ala Ser Glu Arg
385 390 395 400
aag gcg tgg cct agc ccg gac cag gtc tac caa tgc ctc atc aac acc 1248
Lys Ala Trp Pro Ser Pro Asp Gln Val Tyr Gln Cys Leu Ile Asn Thr
405 410 415
gcc gag gac cta ggg cct tcc ggt tgg gac ccg gaa tac ggc ttc ggc 1296
Ala Glu Asp Leu Gly Pro Ser Gly Trp Asp Pro Glu Tyr Gly Phe Gly
420 425 430
ctg gtc cgg gcc gac cgg gcg atg acg gac acc acc tac tgc ttc ccc 1344
Leu Val Arg Ala Asp Arg Ala Met Thr Asp Thr Thr Tyr Cys Phe Pro
435 440 445
gga tcc gaa ttc aag ctt gtc gac ctg cag tct cat cac cat cat cac 1392
Gly Ser Glu Phe Lys Leu Val Asp Leu Gln Ser His His His His His
450 455 460
cac taa 1398
His
465
<210> 5
<211> 1404
<212> DNA
<213> Thermus thermophilus HB8
<220>
<221> CDS
<222> (1)..(1404)
<220>
<221> yurI SP
<222> (1)..(84)
<220>
<221> thermophilic neutral protease
<222> (85)..(1404)
<400> 5
atg aca aaa aaa gca tgg ttt ctg ccg ctc gtc tgt gta tta ctg att 48
Met Thr Lys Lys Ala Trp Phe Leu Pro Leu Val Cys Val Leu Leu Ile
1 5 n 10 15
tcc gga tgg ctt gcg cca gca gct tca gca agc gcg gcg gcc ggt gca 96
Ser Gly Trp Leu Ala Pro Ala Ala Ser Ala Ser Ala Ala Ala Gly Ala
20 25 30
cat atg gag ctc ccc cag acc cca ccg ccg ccc gtg aac ccc gcc gag 144
His Met Glu Leu Pro Gln Thr Pro Pro Pro Pro Val Asn Pro Ala Glu
35 40 45
tgc ccg gta ggt ccc ctg cgg gtg cag agc ctg gat gct cct tct aag 192
Cys Pro Val Gly Pro Leu Arg Val Gln Ser Leu Asp Ala Pro Ser Lys
50 55 60
ctg cac ggt ttg gga agc ttt aaa ggg gag ttc gtt ccg gga gaa ctc 240
Leu His Gly Leu Gly Ser Phe Lys Gly Glu Phe Val Pro Gly Glu Leu
65 70 75 80
att gta gtg ccc aaa cca ggt ctt tcc ctt cag agc ttg cgg gcc tca 288
Ile Val Val Pro Lys Pro Gly Leu Ser Leu Gln Ser Leu Arg Ala Ser
85 90 95
gga gta gag ccc cag gcc cag ctc gcc ctg gac gta atc aag gtg aag 336
Gly Val Glu Pro Gln Ala Gln Leu Ala Leu Asp Val Ile Lys Val Lys
100 105 110
gtt ccc cat ggg gag gag aaa gtc cga gcg gaa gct ctt ttg cgg gcg 384
Val Pro His Gly Glu Glu Lys Val Arg Ala Glu Ala Leu Leu Arg Ala
115 120 125
ggt gct cag tat gtc cag ccc aac tac gtt tac cgg cct ttg cgg gct 432
Gly Ala Gln Tyr Val Gln Pro Asn Tyr Val Tyr Arg Pro Leu Arg Ala
130 135 140
ccg aat gac ctc tat tac ccc gat caa agc gcc tac ttg aat cgg ttg 480
Pro Asn Asp Leu Tyr Tyr Pro Asp Gln Ser Ala Tyr Leu Asn Arg Leu
145 150 155 160
gtg cgc tta gaa agc gct tgg gac ttc agc aca ggc agg gga tgc ccg 528
Val Arg Leu Glu Ser Ala Trp Asp Phe Ser Thr Gly Arg Gly Cys Pro
165 170 175
ccc ctt gtg gcc gtg cta gac acg gga gtt ctt gcc cac gag gac ttt 576
Pro Leu Val Ala Val Leu Asp Thr Gly Val Leu Ala His Glu Asp Phe
180 185 190
cag gcc agc aag tac ctc ccc gcc ggg gtt aac ctg gac gtg gct gac 624
Gln Ala Ser Lys Tyr Leu Pro Ala Gly Val Asn Leu Asp Val Ala Asp
195 200 205
gga gat gcc aat ccc acg gac gac tcg gct ccc aac aat tgg ggg cat 672
Gly Asp Ala Asn Pro Thr Asp Asp Ser Ala Pro Asn Asn Trp Gly His
210 215 220
ggt tta gag gtg gcc tcg gtc ttg ggg gcg gat acc aac aac tct aag 720
Gly Leu Glu Val Ala Ser Val Leu Gly Ala Asp Thr Asn Asn Ser Lys
225 230 235 240
gga ata gca gga act acc tgg ggt gga tac gtt gtt cca atc aag gtt 768
Gly Ile Ala Gly Thr Thr Trp Gly Gly Tyr Val Val Pro Ile Lys Val
245 250 255
ttc tac cgg ggt ggt gga gcc acg tat gaa acc ctt ttc aag ggg gtt 816
Phe Tyr Arg Gly Gly Gly Ala Thr Tyr Glu Thr Leu Phe Lys Gly Val
260 265 270
cgg tta gcc cgc caa ctg ggg gcc cag gtc atc aac att tcg ctg ggg 864
Arg Leu Ala Arg Gln Leu Gly Ala Gln Val Ile Asn Ile Ser Leu Gly
275 280 285
ggt aac gac tat gac gag gtt ctg gat gag gag ctg gcc cgg gct cgg 912
Gly Asn Asp Tyr Asp Glu Val Leu Asp Glu Glu Leu Ala Arg Ala Arg
290 295 300
aac gag ggg agg gtt att gta gct gcg gcg gga aac tac gag acc ggg 960
Asn Glu Gly Arg Val Ile Val Ala Ala Ala Gly Asn Tyr Glu Thr Gly
305 310 315 320
aat ggg gga ccg gtt atg ttc cct gcc agc agc ccc aac act ctc gct 1008
Asn Gly Gly Pro Val Met Phe Pro Ala Ser Ser Pro Asn Thr Leu Ala
325 330 335
gtg ggt gcg gta gat ctc ctt aaa agg cgg gcg aat ttt tcg gcc tat 1056
Val Gly Ala Val Asp Leu Leu Lys Arg Arg Ala Asn Phe Ser Ala Tyr
340 345 350
ggc ccc gag ctt gac cta atg gct cca ggg gtg gag gtt ttg gcg gca 1104
Gly Pro Glu Leu Asp Leu Met Ala Pro Gly Val Glu Val Leu Ala Ala
355 360 365
ggc cct tca ggc aac tat cgc ttt gtg agc ggc acc tct ttg gct agc 1152
Gly Pro Ser Gly Asn Tyr Arg Phe Val Ser Gly Thr Ser Leu Ala Ser
370 375 380
ccc atc gtg gcc ggg gtg gtg gcc ctc tac atg agc aag tac gcc agc 1200
Pro Ile Val Ala Gly Val Val Ala Leu Tyr Met Ser Lys Tyr Ala Ser
385 390 395 400
gag cgg aag gcg tgg cct agc ccg gac cag gtc tac caa tgc ctc atc 1248
Glu Arg Lys Ala Trp Pro Ser Pro Asp Gln Val Tyr Gln Cys Leu Ile
405 410 415
aac acc gcc gag gac cta ggg cct tcc ggt tgg gac ccg gaa tac ggc 1296
Asn Thr Ala Glu Asp Leu Gly Pro Ser Gly Trp Asp Pro Glu Tyr Gly
420 425 430
ttc ggc ctg gtc cgg gcc gac cgg gcg atg acg gac acc acc tac tgc 1344
Phe Gly Leu Val Arg Ala Asp Arg Ala Met Thr Asp Thr Thr Tyr Cys
435 440 445
ttc ccc gga tcc gaa ttc aag ctt gtc gac ctg cag tct cat cac cat 1392
Phe Pro Gly Ser Glu Phe Lys Leu Val Asp Leu Gln Ser His His His
450 455 460
cat cac cac taa 1404
His His His
465
<210> 6
<211> 1431
<212> DNA
<213> Thermus thermophilus HB8
<220>
<221> CDS
<222> (1)..(1431)
<220>
<221> yrrS SP
<222> (1)..(111)
<220>
<221> thermophilic neutral protease
<222> (112)..(1431)
<400> 6
atg agc aat aat caa tct cgt tat gaa aat cgt gat aaa cgc aga aaa 48
Met Ser Asn Asn Gln Ser Arg Tyr Glu Asn Arg Asp Lys Arg Arg Lys
1 5 10 15
gcc aat tta gtg ctt aac att tta atc gca atc gta tcc ata cta att 96
Ala Asn Leu Val Leu Asn Ile Leu Ile Ala Ile Val Ser Ile Leu Ile
20 25 30
gtc gta gta gca gcg gcg gcc ggt gca cat atg gag ctc ccc cag acc 144
Val Val Val Ala Ala Ala Ala Gly Ala His Met Glu Leu Pro Gln Thr
35 40 45
cca ccg ccg ccc gtg aac ccc gcc gag tgc ccg gta ggt ccc ctg cgg 192
Pro Pro Pro Pro Val Asn Pro Ala Glu Cys Pro Val Gly Pro Leu Arg
50 55 60
gtg cag agc ctg gat gct cct tct aag ctg cac ggt ttg gga agc ttt 240
Val Gln Ser Leu Asp Ala Pro Ser Lys Leu His Gly Leu Gly Ser Phe
65 70 75 80
aaa ggg gag ttc gtt ccg gga gaa ctc att gta gtg ccc aaa cca ggt 288
Lys Gly Glu Phe Val Pro Gly Glu Leu Ile Val Val Pro Lys Pro Gly
85 90 95
ctt tcc ctt cag agc ttg cgg gcc tca gga gta gag ccc cag gcc cag 336
Leu Ser Leu Gln Ser Leu Arg Ala Ser Gly Val Glu Pro Gln Ala Gln
100 105 110
ctc gcc ctg gac gta atc aag gtg aag gtt ccc cat ggg gag gag aaa 384
Leu Ala Leu Asp Val Ile Lys Val Lys Val Pro His Gly Glu Glu Lys
115 120 125
gtc cga gcg gaa gct ctt ttg cgg gcg ggt gct cag tat gtc cag ccc 432
Val Arg Ala Glu Ala Leu Leu Arg Ala Gly Ala Gln Tyr Val Gln Pro
130 135 140
aac tac gtt tac cgg cct ttg cgg gct ccg aat gac ctc tat tac ccc 480
Asn Tyr Val Tyr Arg Pro Leu Arg Ala Pro Asn Asp Leu Tyr Tyr Pro
145 150 155 160
gat caa agc gcc tac ttg aat cgg ttg gtg cgc tta gaa agc gct tgg 528
Asp Gln Ser Ala Tyr Leu Asn Arg Leu Val Arg Leu Glu Ser Ala Trp
165 170 175
gac ttc agc aca ggc agg gga tgc ccg ccc ctt gtg gcc gtg cta gac 576
Asp Phe Ser Thr Gly Arg Gly Cys Pro Pro Leu Val Ala Val Leu Asp
180 185 190
acg gga gtt ctt gcc cac gag gac ttt cag gcc agc aag tac ctc ccc 624
Thr Gly Val Leu Ala His Glu Asp Phe Gln Ala Ser Lys Tyr Leu Pro
195 200 205
gcc ggg gtt aac ctg gac gtg gct gac gga gat gcc aat ccc acg gac 672
Ala Gly Val Asn Leu Asp Val Ala Asp Gly Asp Ala Asn Pro Thr Asp
210 215 220
gac tcg gct ccc aac aat tgg ggg cat ggt tta gag gtg gcc tcg gtc 720
Asp Ser Ala Pro Asn Asn Trp Gly His Gly Leu Glu Val Ala Ser Val
225 230 235 240
ttg ggg gcg gat acc aac aac tct aag gga ata gca gga act acc tgg 768
Leu Gly Ala Asp Thr Asn Asn Ser Lys Gly Ile Ala Gly Thr Thr Trp
245 250 255
ggt gga tac gtt gtt cca atc aag gtt ttc tac cgg ggt ggt gga gcc 816
Gly Gly Tyr Val Val Pro Ile Lys Val Phe Tyr Arg Gly Gly Gly Ala
260 265 270
acg tat gaa acc ctt ttc aag ggg gtt cgg tta gcc cgc caa ctg ggg 864
Thr Tyr Glu Thr Leu Phe Lys Gly Val Arg Leu Ala Arg Gln Leu Gly
275 280 285
gcc cag gtc atc aac att tcg ctg ggg ggt aac gac tat gac gag gtt 912
Ala Gln Val Ile Asn Ile Ser Leu Gly Gly Asn Asp Tyr Asp Glu Val
290 295 300
ctg gat gag gag ctg gcc cgg gct cgg aac gag ggg agg gtt att gta 960
Leu Asp Glu Glu Leu Ala Arg Ala Arg Asn Glu Gly Arg Val Ile Val
305 310 315 320
gct gcg gcg gga aac tac gag acc ggg aat ggg gga ccg gtt atg ttc 1008
Ala Ala Ala Gly Asn Tyr Glu Thr Gly Asn Gly Gly Pro Val Met Phe
325 330 335
cct gcc agc agc ccc aac act ctc gct gtg ggt gcg gta gat ctc ctt 1056
Pro Ala Ser Ser Pro Asn Thr Leu Ala Val Gly Ala Val Asp Leu Leu
340 345 350
aaa agg cgg gcg aat ttt tcg gcc tat ggc ccc gag ctt gac cta atg 1104
Lys Arg Arg Ala Asn Phe Ser Ala Tyr Gly Pro Glu Leu Asp Leu Met
355 360 365
gct cca ggg gtg gag gtt ttg gcg gca ggc cct tca ggc aac tat cgc 1152
Ala Pro Gly Val Glu Val Leu Ala Ala Gly Pro Ser Gly Asn Tyr Arg
370 375 380
ttt gtg agc ggc acc tct ttg gct agc ccc atc gtg gcc ggg gtg gtg 1200
Phe Val Ser Gly Thr Ser Leu Ala Ser Pro Ile Val Ala Gly Val Val
385 390 395 400
gcc ctc tac atg agc aag tac gcc agc gag cgg aag gcg tgg cct agc 1248
Ala Leu Tyr Met Ser Lys Tyr Ala Ser Glu Arg Lys Ala Trp Pro Ser
405 410 415
ccg gac cag gtc tac caa tgc ctc atc aac acc gcc gag gac cta ggg 1296
Pro Asp Gln Val Tyr Gln Cys Leu Ile Asn Thr Ala Glu Asp Leu Gly
420 425 430
cct tcc ggt tgg gac ccg gaa tac ggc ttc ggc ctg gtc cgg gcc gac 1344
Pro Ser Gly Trp Asp Pro Glu Tyr Gly Phe Gly Leu Val Arg Ala Asp
435 440 445
cgg gcg atg acg gac acc acc tac tgc ttc ccc gga tcc gaa ttc aag 1392
Arg Ala Met Thr Asp Thr Thr Tyr Cys Phe Pro Gly Ser Glu Phe Lys
450 455 460
ctt gtc gac ctg cag tct cat cac cat cat cac cac taa 1431
Leu Val Asp Leu Gln Ser His His His His His His
465 470 475
Claims (2)
1. A recombinant thermophilic neutral protease with secretion signal peptide sequence has the amino acid sequence shown in SEQ ID No.1, SEQ ID No.3 or SEQ ID No. 4.
2. The application of recombinant thermophilic neutral protease without secretion signal peptide sequence in decomposing protein is that the recombinant thermophilic neutral protease is secreted by bacillus subtilis in the form of pro-peptide sequence, and has the amino acid sequence shown in SEQ ID No.2 and has protease hydrolysis activity without self-shearing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210505122.0A CN115260314B (en) | 2022-05-10 | 2022-05-10 | Recombinant thermophilic neutral protease and application thereof in degradation of protein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210505122.0A CN115260314B (en) | 2022-05-10 | 2022-05-10 | Recombinant thermophilic neutral protease and application thereof in degradation of protein |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115260314A CN115260314A (en) | 2022-11-01 |
CN115260314B true CN115260314B (en) | 2023-10-24 |
Family
ID=83760122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210505122.0A Active CN115260314B (en) | 2022-05-10 | 2022-05-10 | Recombinant thermophilic neutral protease and application thereof in degradation of protein |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115260314B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5622841A (en) * | 1992-05-27 | 1997-04-22 | Novo Nordisk Biotech, Inc. | Method for the production of heterologous polypeptides using a promoter element and signal peptide of a bacillus gene encoding an alkaline protease |
CN102803290A (en) * | 2009-06-11 | 2012-11-28 | 丹尼斯科美国公司 | Bacillus strain for increased protein production |
CN103289980A (en) * | 2006-07-05 | 2013-09-11 | 催化剂生物科学公司 | Protease screening methods and proteases indentified thererby |
CN107164349A (en) * | 2017-05-24 | 2017-09-15 | 吉林大学 | A kind of thermophilic neutral protease gene, engineering bacteria, enzyme and its application |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6960462B2 (en) * | 2000-02-08 | 2005-11-01 | Dsm Ip Assets B.V | Use of acid-stable subtilisin proteases in animal feed |
-
2022
- 2022-05-10 CN CN202210505122.0A patent/CN115260314B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5622841A (en) * | 1992-05-27 | 1997-04-22 | Novo Nordisk Biotech, Inc. | Method for the production of heterologous polypeptides using a promoter element and signal peptide of a bacillus gene encoding an alkaline protease |
CN103289980A (en) * | 2006-07-05 | 2013-09-11 | 催化剂生物科学公司 | Protease screening methods and proteases indentified thererby |
CN102803290A (en) * | 2009-06-11 | 2012-11-28 | 丹尼斯科美国公司 | Bacillus strain for increased protein production |
CN107164349A (en) * | 2017-05-24 | 2017-09-15 | 吉林大学 | A kind of thermophilic neutral protease gene, engineering bacteria, enzyme and its application |
Non-Patent Citations (4)
Title |
---|
"Heterologous expression and characterization of a novel subtilisin-like protease from a thermophilic Thermus thermophilus HB8";Guiqiu Xie 等;《Int J Biol Macromol》;第138卷;第528-535页 * |
"嗜热蛋白酶Tth0724的枯草杆菌表达及其应用";轩小然;《中国优秀硕士学位论文全文数据库 (基础科学辑)》(第1期);A006-446 * |
Masui,R. 等."Thermus thermophilus HB8 chromosome 1, complete sequence".《genbank》.2021,VERSION NC_006461.1. * |
Miyazaki,K. 等."serine protease [Thermus thermophilus]".《genbank》.2021,ACCESSION BDA37360. * |
Also Published As
Publication number | Publication date |
---|---|
CN115260314A (en) | 2022-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6300116B1 (en) | Modified protease having improved autoproteolytic stability | |
Liu et al. | Purification and properties of a collagenolytic protease produced by Bacillus cereus MBL13 strain | |
AU771078B2 (en) | Subtilase enzymes of the I-S1 and I-S2 sub-groups having an additional amino acid residue in the active site loop region | |
EP1141262A1 (en) | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region | |
KR20130009770A (en) | Performance-enhanced protease variant | |
AU772347B2 (en) | Subtilase enzymes of the I-S1 and I-S2 sub-groups having an additional amino acid residue in an active site loop region | |
CN115260314B (en) | Recombinant thermophilic neutral protease and application thereof in degradation of protein | |
EP1183343A1 (en) | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 125 and 126 | |
KR100767710B1 (en) | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 97 and 98 | |
CN113166747B (en) | Protease variants and uses thereof | |
AU773674B2 (en) | Subtilase enzymes of the I-S1 and I-S2 sub-groups having an additional amino acid residue in an active site loop region | |
CA2355655C (en) | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region | |
Liu et al. | Purifikacija i svojstva kolagenolitičke proteaze proizvedene s pomoću Bacillus cereus MBL13 | |
AU771154B2 (en) | Subtilase enzymes of the I-S1 and I-S2 sub-groups having at least one additional amino acid residue between positions 97 and 98 | |
Liu Lili et al. | Purification and properties of a collagenolytic protease produced by Bacillus cereus MBL13 strain. | |
EP1141260A1 (en) | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region | |
KR20010093167A (en) | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region | |
EP1183342A1 (en) | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 128 and 129 | |
EP1183337A1 (en) | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 132 and 133 | |
EP1183341A1 (en) | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 127 and 128 | |
EP1183339A1 (en) | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 129 and 130 | |
EP1183336A1 (en) | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 131 and 132 | |
WO2000037624A1 (en) | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |